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ABSTRACT
Bone tissue engineering approaches using polymer/ceramic composites show promise as
effective biocompatible, absorbable, and osteoinductive materials. A novel class of in situ
polymerizing thiol-acrylate based copolymers synthesized via an amine-catalyzed Michael
addition was studied for its potential to be used in bone defect repair. Both pentaerythritol
triacrylate-co-trimethylolpropane tris(3-mercaptopropionate) (PETA-co-TMPTMP) and PETAco-TMPTMP with hydroxyapatite composites were fabricated in solid cast and foamed forms.
These materials were characterized chemically and mechanically followed by an in vitro
evaluation of the biocompatibility and chemical stability in conjunction with human adiposederived mesenchymal pluripotent stem cells (hASC). The solid PETA-co-TMPTMP with and
without hydroxyapatite (HA) exhibited compressive strength in the range of 7-20 MPa, while the
cytotoxicity and biocompatibility results demonstrate higher metabolic activity of hASC on
PETA-co-TMPTMP than on a polycaprolactone control. SEM imaging of hASC show expected
spindle shaped morphology when adhered to copolymer. Micro-CT analysis indicates open cell
interconnected pores. Foamed PETA-co-TMPTMP HA composite shows promise as an
alternative to FDA-approved biopolymers for bone tissue engineering applications.
The results of the six week in vivo biocompatibility study using a posterior lumbar spinal
fusion model demonstrate that PETA:HA can be foamed in vivo without serious adverse effects
at the surgical site. Additionally, it was demonstrated that cells migrate into the interconnected
pore volume are found within centers of ossification.
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Because the natural mechanical strength of materials is highly dependent on the crystal
structure, four different silicate-derived ceramics—diopside, akermanite, monticellite, and
merwinite have been synthesized and evaluated for their potential as bone augments and grafts.
This sparks our interest in the fabrication of polycaprolactone (PCL)/ceramic composites for
potential use as scaffolds. Akermanite and monticellite exhibit better osteogenic properties than
diopside and merwinite, suggesting that they might be the optimal material for fabricating bone
scaffolds.

viii

CHAPTER 1. INTRODUCTION
Biomaterial matrices are widely used to deliver genetic material and/or inductive
biochemical signal, which allow developmental control over the delivered stem cells to some
extent. Lots of studies using stem cell-scaffold constructs in regenerative medicine and showed
promising results (Levi & Longaker, 2011b).
1.1 Current biomaterials used in hASC bone tissue engineering strategies
1.1.1 Biological materials
Biologic scaffolds composed of naturally occurring extracellular matrix (ECM) facilitate
constructive remodeling of tissues when used with site specific cells. The use of endogenous
stem cells, modulation of the host innate immune response, and influence of cell differentiation
could cause the remodeling process (Crapo et al., 2013). ECM materials are typically prepared
with decellularization of source tissues, such as adipose and nervous system tissue, and then
made into sheets, powder, or hydrogels. The decellularization is performed during ECM isolation
in order to prevent inflammatory response and/or tissue rejection due to xenogeneic and
allogeneic cellular antigens (Zanetti et al., 2013b). However, ECM still retain the structure and
function original tissue to a large extent (Song & Ott, 2011) and could trigger desirable
immunemediated responses at injury sites in multiple tissue types (Ariganello et al., 2011).
Biologic scaffolds composed of ECM have been used in many studies to facilitate constructive
remodeling in several tissues, including dura mater, bone, cartilage (Yang et al., 2008), cardiac
muscles (Robinson et al., 2005), and peripheral and central nervous system(Crapo et al., 2013;
Martini, 1994).
In other studies, fibrin hydrogel were used as bone scaffolds. hASC were initially loaded on a
fibrin hydrogel and then the hASC-fibrin hydrogel was wrapped around an orthopaedic construct
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to treat bone or cartilage defect (Hankemeier et al., 2007; Wang et al., 2010b). Therefore, the
understanding of the biomechanical properties of the ECM loaded with hASC will be critical to
future clinical use.
1.1.2 Synthetic polymers
Biocompatible synthetic polymers can be produced reproducibly in bulk and in highly
purified forms. Polyester polymers such asPCL, PGA, PLLA and their copolymer PLGA, which
have been shown to support hASC proliferation and differentiation, are the most popular
synthetic polymeric materials in bone tissue engineering.(Guven et al., 2011; Jeon et al., 2008;
Lee et al., 2011; Levi et al., 2010; Wang et al., 2010a)
Polycaprolactone (PCL)
Polycaprolactone (PCL) is formed through ring-opening polymerization and has
repeating units of one ester group and five methylene groups. The degradation of PCL is done in
two steps, random hydrolysis of ester bonds and weight loss due to the diffusion of oligomeric
sort from the volume(Sabir et al., 2009). PCL degrades slowly and it can last for up to 2 years in
vivo(van Gaalen et al., 2008) . As a versatile polymeric material, PCL has been made into
nanofibers by eletrospinning and after seeding the cells on PCL nanofibers, mineralization and
type I collagen were observed on the scaffolds(Yoshimoto et al., 2003).
Poly lactic acid (PLLA)
PLLA is produced by the cyclic dimer of lactic acid that exists as two optical isomers. D
&L- lactate is the isomer in natural form, as well as DL-lactide, which is the synthetic mixture of
D-lactide and L-lactide (Sabir et al., 2009). Poly (lactic acid) also can be degraded by the
homogenous hydrolysis erosion, releasing non-biocompatible products (acids) that can
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dramatically change the scaffold microenvironment leading to cell death. The biocompatibility of
PLLA scaffolds could be improved by combining in collagen or BMP-2, and used to treat
segmental defect model in rat. Neo bone tissue was observed after 12 week after implantation of
PLLA scaffolds (Liao et al., 2004).
Poly glycolic acid (PGA)
PGA is a rigid thermoplastic material, with high melting temperature and more
hydrophilic than PLA. It is not soluble in most organic solvents due to the high crystallinity
(Sabir et al., 2009). PGA can be fabricated in various ways such as extrusion, injection, and
compression molding. The properties and the degradation can be affected by the type of
processing technique. PGA, when fabricated with triple amount of β-TCP, exhibited a strong
ability for osteogenesis, mineralization and biodegradation for bone replacement (Cao &
Kuboyama, 2010). PGA was also made into an injectable copolymer with PLA and demonstrated
to be a suitable osteoconductive material to treat critical size bone defects (Rimondini et al.,
2005).
Poly (D,L-lactide-co-glycolide) PLGA
Copolymerization of PLLA and PGA produce PLGA, which is amorphous, and has a
slower degradation rate and weaker mechanical strength compared to PLLA. Bone scaffolds are
also made of PLGA and have been demonstrate to accelerate bone healing. Furthermore, PLGA
scaffolds induce more rapid bone formation than untreated controls (Karp et al., 2003). Marra et
al. mixed HAP granules into poly(caprolactone) and PLGA blends and observed the formation of
collagen layer on the scaffold.(Marra et al., 1999)
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In comparison to the above techniques the amine catalyzed thiol-acrylate reaction utilized
in this study is unique as it proceeds though as anionic step growth mechanism. Normally
anionic polymerization mechanisms proceed via a chain growth mechanism.

This amine

catalyzed thiol-acrylate mechanism proceeds via a chain “process” with sequential chain transfer
steps with each addition causing the polymerization to follow the rules and attributes of a step
growth mechanism in terms of molecular weight and physical properties. The general reaction
scheme below is described in Bounds et al.(Bounds et al.)

Figure 1.1 Scheme of Amine Catalyzed Thiol-Acrylate Reaction
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1.1.3 Ceramics
Bone is composed of hydroxyapatite (HA) crystals distributed within an organic matrix
with porosity and percent mineralization varying among bone types.(Pallua & Suscheck, 2010a)
The use of calcium phosphate ceramics as bone substitutes dates back more than 30 years to the
field of dental implantation(Ambard & Mueninghoff, 2006). However, one of the main
disadvantage of calcium phosphates is their weak mechanical strength, especially they are brittle
and have poor fatigue resistance (Vallet‐Regí & Ruiz‐Hernández, 2011). Highly porous
bioceramics and scaffolds have even weaker mechanical strength. Consequently, for biomedical
applications, calcium phosphates are primarily used as fillers and coatings. Kim et al observed
higher alkaline phosphatase activity of the proliferated cells on porous ZrO2 bone scaffold
coated with hydroxyapatite than pure ZrO2 scaffolds(Kim et al., 2003a). It is generally agreed
that ceramic biomaterials used in bone tissue engineering applications should mimic the natural
bone structure to support cell attachment and migration within the porous materials (Zanetti et
al., 2013b).

β-tricalcium phosphate (β-TCP), is a synthetic apatite that shows great

osteoconductive and osteoinductive properties compared to HA both in vitro and in vivo (Dong
et al., 2002; Kwon et al., 2003; Yuan et al., 2001). Lately, Liu et al. evaluated the osteogenic
potential of hASC loaded in β-TCP and akermanite scaffolds and demonstrated that Akermanite
(Ca2MgSi2O7) has a stable degradation rate and superior bone deposition compared to β-TCP
constructs (Liu et al., 2008b). Furthermore, akermanite scaffolds are able to improve hASCs’
osteogenic commitment since the cells have a strong affinity for Ca, Mg, and Si ions deposited
on scaffold(Liu et al., 2008b). Diopside, another ceramic similar to akermanite, has been
demonstrated to precipitate apatite mineral in simulated body fluid (SBF),(Iwata et al., 2004b)
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support osteoblast culture(Wu & Chang, 2007a) and to form bone/ceramic interfaces in rabbit
models of osteointegration.(Nonami & Tsutsumi, 1999) The bioactivity of diopside composites
has also recently been explored in SBF. Sainz et al. evaluated the thermodynamic stability of a
blend of wollatonite and diopside in finding that higher diopside content resulted in a more stable
chemically stable substrate.(Sainz et al., 2010) Another recent study found that increased
diopside content in Al2O3/diopside ceramic composites led to increased calcium deposition in
SBF.(Zhang et al., 2010a) Zhang et al. found substantial mineral growth on the surface of
HA/diopside composites immersed in SBF. Unfortunately, this study did not have adequate
controls or analysis to determine the nature of the mineral formations.(Zhang et al., 2011) We are
particularly interested this phase because of the dimensionality of the structure type. It is similar
to akermanite and will expand our interest in understanding the role of structure and preparation
in the strength and bioactivity of ceramics for bone scaffolding.
In addition to magnesium and silicon, strontium an alkaline earth element similar to calcium,
has long been known as bioactive trace component of bone and has been explored as a treatment
for osteoporosis.(Dahl et al., 2001; Shorr & Carter, 1952) Several recent studies have doped
strontium into ceramics such calcium polyphosphate, hydroxyapatite, and hardystonite where in
low percentages (wt/wt) strontium doped ceramics were found to up regulate osteogenic markers
in vitro and increase bone volume in vivo. (Landi et al., 2007; Qiu et al., 2006; Tian et al., 2009;
Zreiqat et al., 2010)
It is important to note that ceramic materials prepared in the techniques as published typically
have impurities and are not crystalline. To correlate osteogenic properties with composition it is
critical to study phase-pure materials and in the proposed project, we plan to prepare ceramics
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with multiple heat treatments to reach sample equilibrium and carefully monitoring phase
formation.
It is clear that scaffold technology plays a critical role in the success of the current stem cell
based bone tissue engineering paradigms. While a variety of different materials, both ceramics
and polymers, have been tested in combination with hASC, it has been noted by Lendeckel et al.
and others that composite scaffolds may offer a better clinical outcome as a result of improved
mechanical and biological properties.(Lendeckel et al., 2004) The study detailed in disseration
will explore diopside, monticellite and merwinite, similar in composition to akermanite, as
osteogenic components of PCL composites for potential use in bone defect repair.
1.2 Scaffolds fabrication method
Solvent casting
Solvent casting or particulate leaching is generally used to make scaffolds at room
temperature. For this method, polymers like PLLA or PLGA dissolved in an organic solvent such
as chloroform first and then into a mold containing solid crystals. These salt crystals are
insoluble in the organic solvent, however, could be leached out by immersing the scaffold in
water to form a pore structure within the scaffold (Liao et al., 2002; Mozafari et al., 2010).
Using different size and morphology of the salt crystals could change the pore size and
porosity of scaffolds. The disadvantages of the this method include the extensive use of toxic
organic solvents, long time required for solvent removal (days-to-weeks), residual particles in the
scaffolds, as well as insufficient interconnectivity (Hutmacher, 2000).
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Thermally induced phase separation.
High volume of inter-connected micropore structure of bone scaffolds could be created
through thermal precipitation method (Hutmacher, 2000). Briefly, the polymer was dissolved in
organic solvents (1,4-dioxane or dimethylcarbonate) to produce a homogeneous mixture then
mixed with ceramics powder.
The solution was freeze under -70oC for 24 hours and freeze-dry in a vacuum oven till
reaching a constant weight (Maquet et al., 2004). Such method could be used to prepare
PCL/Hydroxyapatite (Zargarian & Haddadi-Asl, 2010), PLLA/TCP composite scaffolds (Xiong
et al., 2002).
Material Injections
Injectable pastes have been developed for use as a fixation material or to fabricate bone
constructs for cell ingrowth or proceeding. Injectable materials have an advantage over presculpted scaffolds since they can conform to any shape that they are pressed into. In this method,
polymerization can be done in situ (Shin et al., 2003; Temenoff & Mikos, 2000). Injectable
calcium phosphate cements (CPC) have been widely used for filling of bone defects near the
joint since 1980s but they have a low flexural and tensile strength (Brown & Chow, 1983;
Larsson, 2010; LeGeros et al., 1982).
Generally, properties of the injectable materials, such as viscosity, setting time, and initial
mechanical strength, are important for their potential application as bone scaffolds. By using
material injections, the material can fill the gaps in the defect regardless of defect shape and also
it is easy to incorporate bioactive and therapeutic agents by mixing them together with the
injectable materials(Di Martino et al., 2005).
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Gas-Foaming Process
Gas foaming process can also be used to fabricate polymer foams with high porosity
without using highly toxic organic solvents (Cooper, 2000; Harris et al., 1998; Mooney et al.,
1996).
Carbon dioxide (CO2) is usually used as gas porogen for foaming the polymer. Solid
polymers are saturated with CO2 when exposed to high pressure of CO2 gas. By using this
approach, the porosity of polymer foam can reach up to 93% with pore size around 100 µm.
However, gas-foaming results in a closed pore surface and with only 10–30% of interconnected
pores.
Combing particulate leaching method with gas foaming could significantly improve the
pores interconnectivity of scaffolds (Liu & Ma, 2004). However, completely eliminating closed
pores is still a great challenge (Mooney et al., 1996).
3D Printing
Rapid prototyping, especially 3D printing, is becoming more and more popular to create
custom implants based on individual need (Leukers et al., 2005). 3D Printing uses ink-jet
printing technology to precisely place a ‘‘binder’’ solution on a bed of powder. It glues the
powder together in a cross-sectional layer; any powdered material, including polymers, metals,
or ceramics can be fused using an ink-jet head in theory (Stevens et al., 2008).
A starch-based polymer powders (corn starch, dextran and gelatin) was made via 3D
printing process (Lam et al., 2002). Furthermore, hydroxyapatite scaffolds has been successfully
fabricated by 3D printing technology and cells proliferated deep into the structure forming close
contact to Hydroxyapatite granules (Leukers et al., 2005).
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Other applied scaffold fabrication technologies
Other techniques for scaffold fabrication also include membrane lamination, fabrication of nonwoven, emulsion freeze drying, supercritical-fluid technology and fused deposition modeling.
Table 1.1summarizes the key characteristics and parameters of the techniques currently used.
Table 1.1 Key characteristics and parameters of the techniques currently used
Fabrication
technology
Membrane
lamination
Fabrication of
non-woven
Emulsion
freeze drying
Supercriticalfluid
technology
Fused
deposition
modelling

Material
properties
required for
processing

Porosity
in %

Architecture

Soluble

<85

Irregular pore structure

Fibers

<95

Insufficient mechanical properties

Casting

Soluble

<97

High volume of inter-connected
micropore structure

Casting

Amorphous

10-30

High volume of non-interconnected
micropore structure

<90

100% interconnected macropore
structure (triangles, pentagons,
honey comb, etc.),design and
fabrication layer by layer

Processing
Solvent
bonding
Carding,
Needling,
Plate pressing

Solid free
form
fabrication

Thermoplastic

1.3 Animal models used in bone tissue engineering
Rat is one of the most commonly used animals in medical research. However, there are
significant dissimilarities between rat and human bone. In addition,

rats are improper for

emulating multiple implants simultaneously due the limitations of (Mooney & Siegel, 2005).
Other animal models have been established to study parameters that affect bone healing.
These animal models include dog (mongrel, beagle, foxhound, terrier, and bulldog),
rabbit, guinea pig, and sheep. Growth factors, bone graft scaffolds, and macroscopic/microscopic
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changes after different treatment were studies by using these models(Grynpas et al., 2002;
Reichert et al., 2013; Viateau et al., 2007; Wang et al., 2010b).
Rodents
The most commonly used lab animal model is the rat. Rats are inexpensive, easy to raise
and they do not carry the societal concerns compared with other larger animal models
(Liebschner, 2004). Multiple bone implants surgery models, such as spinal fusion, cranial defect
and long bone defect have been used on rats and demonstrated great success (Burdick et al., 2003;
Cook et al., 1994; Lopez et al., 2009). Bone turnover and the effect of diet on this process since
all types of rodents have been studied so extensively in research.
There are, however, disadvantages in the use of rats and mice: they have a limited
naturally occurrence of basic multicellular unit based remodeling; another limitation is the
absence of impaired osteoblast function during the late stages of estrogen deficiency (Liebschner,
2004). It is also impossible to collect large blood samples or obtain several biopsies in such a
small animal for long term studies(Mooney & Siegel, 2005) .
Canine
The dog model is the most commonly used animal model for studying the spinal fusion
process. A lot of literatures compare canine and human bone with regard to the usefulness of the
dog as a model for human orthopaedic conditions. A major disadvantage of these dog models is
that solid fusion always occurs, which is different from clinical situations in humans(Liebschner,
2004).
Trabecular bone from the distal femur of human’s and dog’s is similar in terms of
mechanical and mass properties, but differs in ultimate strain resistance, indicating that canine
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trabecular bone is able to withstand higher compressive strains before failure than human bone
(Choi & Goldstein, 1992). Callewart et al. evaluated the dog spinal fusion method to determine
the rate of fusion after decortication with autogenous bone grafting versus dicortication alone
and found out 100% of the decorticated facets with iliac graft and 75% of the facet sites with
decortication alone were determined to be fused after 6 months by manual testing (Schimandle &
Boden, 1994) .
Sheep and Goats
The number of using sheep is increasing over the last decade and sheep were widely used
in orthopedic research involving fractures, osteoporosis, bone-lengthening and osteoarthritis.
Adult sheep weigh more similar human’s body and have long bones of dimensions suitable for
the implantation of human implants (Newman et al., 1995).
The bone structure of the sheep is quite different from human being histologically
although sheep bones are relatively close to human bones.
In sheep, bone contains principally of primary bone (de Kleer, 2006) in contrast to the
largely secondary, haversian bone composition in humans(Eitel et al., 1981). Kon et al. (Kon et
al., 2000) have evaluated the potential of BMSCs (bone marrow derived stem cells) to repair
bone defects in vivo in a sheep model.
They created a critical size defect in the sheep tibia and implanted an appropriately
designed porous scaffold made of pure HA into the missing segment. Ceramics scaffolds were
either seeded with BMSCs or left empty.
Even though bone formation was histologically observed in both cell-seeded and not
seeded implants, in the former bone formation was found to occur both within the internal

12

macropore space and around the HAC cylinder while in the latter bone formation was limited
mostly to the outer surface and was not observed in most of the inner pores. Furthermore in an
indentation assay, the stiffness of the complex HA-bone material was found to be higher in cellseeded implants than in constructs alone.
Table 1.2 Summary of four key attributes in terms of similarity between animal and human bone
(Pearce et al., 2007)
Canine

Sheep/Goat

Rodents

Macrostructure

++

+++

+

Microstructure

++

+

+

Bone Composition

+++

+++

+

Bone Remodelling

++

+++

++
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CHAPTER 2 THIOL-ACRYLATE NANOCOMPOSITE FOAMS FOR CRITICAL SIZE
BONE DEFECT REPAIR: A NOVEL BIOMATERIAL1
2.1 Introduction
Bone tissue engineering shows promise as an alternative strategy to current surgical
techniques to replace or restore the function of traumatized, damaged, or lost bone.(Gaalen et al.,
2008; Pallua & Suscheck, 2010a) Over the past several decades, bone grafts have advanced as
standard treatment to augment or accelerate bone regeneration.(Pallua & Suscheck, 2010a)
Autogenous cancellous bone grafts have long been used to facilitate bone regrowth, although
quantity is limited and surgical procedures for graft harvest are required. Allogeneic bone grafts
are costly, require time-consuming bone banking procedures, and have high potential for disease
transmission. Neither technique provides a clinically convenient method for conformal filling of
a critical sized bone defect compared to a proposed injectable biomaterial providing mechanical
support and biological cues to support bone regrowth.
To date, a clear trend towards the use of composite scaffolds as an alternative to allogenic or
autogenic bone can be observed in many of the current models.(Hwang & Todo, 2012; Liu et al.,
2012; Ravichandran et al., 2012; Wu et al., 2012) Native bone is composed of naturally
occurring hydroxyapatite (HA) crystals distributed within an organic matrix, with porosity and
percent mineralization varying among bone types.(Pallua & Suscheck, 2010b) Synthetic HA has
been widely used in bone scaffold fabrication because it possesses osteogenic properties.(Jeon et
al., 2012; Ohba et al., 2012) While several of these studies involved the use of extracellular
matrix or other natural occurring compounds such as collagen, decellularized bone or chitosan,
synthetic polymers can be highly pure, readily reproducible and have adaptable mechanical,

1
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chemical, and biological properties to suit specific clinical applications. Much of the research
utilizing synthetic polymers in hASC-combined tissue engineering has been focused on hybrid
cell/scaffold constructs using degradable polyester polymers such as poly(lactide-co-glycolide)
(PLGA), poly(L-lactide) (PLLA), and poly-ɛ-caprolactone (PCL).
Thiol-ene chemistry possesses many advantageous properties for tissue engineering
applications.2-5 Specifically thiol-acrylate chemistry has already been used in biomedical
applications, but has only been explored in photolytically polymerized systems.(Rydholm et al.,
2005; Rydholm et al., 2008; Rydholm et al., 2006) Thiol-acrylate polymers synthesized via an
amine-catalyzed Michael addition reaction have not been explored for biomedical applications.
Scheme 1 displays how the general reaction proceeds by the formation of a catalyst/comonomer
molecule through the Michael addition of the secondary diethylamine across the double bond
found in acrylate monomers. These activated acrylates were then individually mixed with a thiol
comonomer (TMPTMP). This in situ tertiary amine catalyzed Michael addition proceeds via a
chain “process” due to the sequential chain transfer step after each addition. The Michael
addition reaction causes the polymerization to follow the rules and attributes of a step-growth
mechanism in terms of molecular weight and physical properties.
In this study, the synthesis and characterization of a novel class of thiol-acrylate
copolymers(Bounds et al.) has been reported. The tunable gel times and mechanical properties
were determined. A series of biocompatibility tests indicate this new synthetic polymer is
capable of supporting human adipose derived stromal cell culture. Furthermore, SEM and microCT studies illustrate the morphology of solid and foamed PETA-co-TMPTMP HA composites.
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These materials are a potentially transformative class of novel biomaterials with the application
for in situ conformal polymerization at the site of trauma.
2.2 Materials and Methods
2.2.1 Preparation of thiol-acrylate materials
All chemicals were used as received. Trimethylolpropane triacrylate (TMPTA),
poly(ethylene glycol) diacrylate(PEGDA) (MW 700), poly(ethylene glycol) diacrylate (PEGDA)
(575), poly-caprolactone(PCL), trimethylolpropane ethoxylate triacrylate (TMPeTA) (MW 912),
trimethylolpropane ethoxylate triacrylate (TMPeTA)(MW 692),

trimethylolpropane tris(3-

mercaptopropianate) (TMPTMP) were obtained from Aldrich. Diethylamine (DEA) was
obtained with 99% purity from AGROS organics, and pentaerythritol triacrylate (PETA) was
obtained from Alfa Aesar.
Several compositions consisting of TMPTMP with di- or tri-functional acrylates listed
above were prepared in a 1:1 functionality ratio. These solutions were subjected to hASC
cytotoxicity and mass loss tests that are further explained below. PETA-co-TMPTMP was
selected for further experimentation. Twenty stock solutions containing PETA with DEA content
ranging from 2.8-35.1% were prepared and subjected to mechanical testing. The 16.1% DEA
concentration was chosen not only for its maximum mechanical strength, but also its gel time
allowed for an appropriate time range needed for mixing and application of the material.
The preparation of the foamed composite material was prepared by adding 16.1%
PETA/DEA stock solution to TMPTMP in a 1:1 molar functionality ratio followed by 3 hours of
mixing. HA (20% wt/wt) was added to the PETA-co-TMPTMP solution and cast into cylindrical
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molds (10x10mm). The foamed composite copolymer was prepared by pouring the PETA-coTMPTMP with HA into a 250 mL pressurized spray canister using 7g-compressed nitrous oxide
as a gaseous porogen. The foamed composite copolymer was expelled from the canister into the
same cylindrical molds used for solid casting. The same foamed procedure was used for the solid
copolymer without HA. Another 20% HA foamed sample was prepared in vitro by foaming
directly into a beaker containing stromal cell medium instead of cylindrical molds to test the
impact of physiological solution on polymerization and foam structure.
2.2.2 Mechanical testing
Compression testing was performed on four specimens of each scaffold type with
cylindrical geometry of 10 mm  10 mm at room temperature using a hydraulic universal testing
machine (Instron Model 5696, Canton, MA, USA) at an extension rate of 0.5 mm/min to a
maximum compression strain of 90%. These scaffold types included foamed PETA-coTMPTMP with HA(20%), in vitro foamed PETA-TMPTMP with HA(20%), foamed PETA-coTMPTMP without HA, and solid PETA-co-TMPTMP.
2.2.3 hASC isolation and culture
Liposuction aspirates from subcutaneous adipose tissue were obtained from three donors.
All tissues were obtained with informed consent under a clinical protocol reviewed and approved
by the Institutional Review Board at the Pennington Biomedical Research Center. Isolation of
hASC was performed as described elsewhere.(Gimble et al., 2010) The initial passage of the
primary cell culture was referred to as “Passage 0” (p0). The cells were passaged after
trypsinization and plated at a density of 5,000 cells/cm2 (‘‘Passage 1’’) for expansion on T125
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flasks in order to attain 80%. Passage 2 of each individual was used for cell viability test after
acute exposure to the scaffold medium extractives and on scaffolds after loading using a spinner
flask.
2.2.4 Mass loss test
Composite copolymer-HA (foam and solid) mass loss as a function of composition was
analyzed with PCL foam prepared through thermally induced phase separation(Zanetti et al.,
Accepted October 4, 2012) serving as a positive control and solid cast PETA composite
providing an internal comparison for previous experiments. All samples were normalized to the
initial mass before media exposure.
The samples were incubated on an orbital shaker with 5mL stromal media at 37oC and
200rpm/min for 7 days.
2.2.5 Extract cytotoxicity
The extracts from the mass loss test were filtered (0.22 μm pore size) and pipetted (100
μL/well) into a 96-well plate previously sub-cultured with hASC (2,500 cells/well) and incubated
in a CO2 incubator at 37ᵒC containing 5% CO2 for 24 hours. The cellular viability on scaffold
cultures was determined using the Alamar blue assay by adding 10 μL Alamar blue reagent to
each well and re-incubated at 37ᵒC in 5% CO2 for 2 h. The fluorescence was measured at an
excitation wavelength of 530 nm and an emission wavelength of 595 nm using a fluorescence
plate reader. The tissue culture treated plastic 96-well plate served as a control substrate.
2.2.6 hASC loading on scaffolds and culture
5 μL (1.0104 cells/μL) of Passage 2 of each donor (n = 3) were pooled and directly
loaded on the top of each sample. After 30 min of incubation at 37 ᵒC and 5% CO2, the opposite
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side of each sample was loaded with the same number of cells by the same approach.
Experimental groups included: PETA-co-TMPTMP solid, PETA-co-TMPTMP foam, PETA-coTMPTMP+HA solid, PETA-co-TMPTMP+HA foam, PCL solid and PCL foam. Scaffolds
loaded with hASC were immediately transferred to new 48-well plates and cultured in stromal
media (DMEM, 10% FBS, and 1% triple antibiotic solution) for 7 days followed by sample
collection to assess cell viability with Alamar blue stain.
2.2.7 In vitro hASC viability on scaffolds with alamar blue stain
The viability of cells within the scaffolds in stromal media was determined after 7 days
using an Alamar Blue™ metabolic activity assay. The scaffolds were removed from culture,
washed three times in PBS, and incubated with 10% Alamar Blue™ in Hank’s balanced salt
solution (HBSS) without phenol red (pH 7) for 90 min. Aliquots (100 μL) of Alamar
Blue™/HBSS were placed in a 96-well plate in triplicate, and the fluorescence was measured at
an excitation wavelength of 530 nm and an emission wavelength of 595 nm using a fluorescence
plate reader.
2.2.8 In vitro hASC viability on scaffolds with picogreen
Scaffolds were sectioned using forceps and then incubated with 0.5 mL proteinase K (0.5
mg/mL) at 56ºC overnight. The mixture was centrifuged for 5 minutes at 108g, and 50 μl
aliquots of the mixture were mixed with 50 μl Picogreen dye solution (0.1 g/mL, Invitrogen) in
96-well plates. Samples were excited at 480 nm and total DNA concentration was compared to
the live control. Scaffold without cells were used to subtract the background fluorescence
emission from all readings.
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2.2.9 SEM analysis
The solid precast PETA-co-TMPTMP polymer was placed in a 12-well plate to form a
thin layer (1mm thickness). The polymers seeded with stem cells were fixed first for 30mins by 2%
glutaraldhyde (GA) (made with 2parts Cocadylate, 1part 8% GA and 1 part distilled H2O). The
samples were subjected to a dehydration procedure by using 30-100% ethanol solution
increasing by 10% increment every 30 minutes. 100% HDMS (Hexamethyldisilazane) was
added to the samples to replace the dried air and ethanol overnight. A conductive platinum
coating was applied using EMS550X sputter coater for 2 minutes followed by standard SEM
analysis. In situ and in vitro foamed samples were also subjected to standard SEM analysis.
2.2.10 Micro-CT analysis
Three PETA-co-TMPTMP foams were fabricated with pressurized extrusion foaming as
described with the first two foams having 0 and 20%HA content. The third sample also had a
20%HA content, but was foamed into stromal media (in vitro). Samples were sliced into 1-2 mm
approximate cuboids of 10-15 mm height. Samples were imaged with 11 keV monochromatic xrays with 2.5 μm/px resolution at the tomography beamline at the Center for Advanced
Microstructures and Devices (Louisiana State University, Baton Rouge, LA). Projections
numbered 720 corresponding to Δθ=0.25; projection exposure time varied between 2 and 4
seconds, but reconstruction algorithms ensure normalized data. The two different datasets are
directly comparable, both as an aggregate dataset and as slices. Reconstruction data are 16-bit
signed integer with mean air intensity scaled to zero. Pore size was measured using ImageJ 64.
Volume renderings were generated from the three foamed samples 3D data using Avizo
7.0.1

(Visualization

Services

Group).

Two
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overlapping

sub-volumes

are

rendered

simultaneously, one with a red-orange-white colormap corresponding to trithiol-triacrylate foam,
and the other with a blue-green colormap corresponding to hydroxyapatite inclusions.
Orthogonal slices were created using ImageJ and have equivalent scale, brightness, contrast, and
grey map settings.
2.2.11 Statistical analysis
All results were expressed as mean ± SEM. Normality of the data was confirmed using
the Shapiro-Wilk test (P < 0.001). Data were analyzed with one or two-way analysis of variance
(ANOVA), followed by Tukey’s minimum significant difference (MSD) post hoc test for
pairwise comparisons of main effects. For all comparisons, a P-value < 0.05 was considered
significant.
2.3 Results and Discussion
Thiol-acrylate chemistry incorporates nearly all of the materials used in the synthesis
process into one complete network greatly reducing the risks of leaching toxic monomers and
short chain oligomers as is observed with other techniques.(Burdick & Anseth, 2002; Nuttelman
et al., 2006) Additionally, bioactive compounds such as peptides can be copolymerized as has
been demonstrated with photoinitiated thiol-acrylate chemistries.(Salinas & Anseth, 2008) Third,
and perhaps most importantly, these materials can rapidly polymerize in situ and in an in vitro
environment through an attached tertiary amine, self-catalyzed “chain” process.
These materials have broadly tunable mechanical and chemical properties in that many
compositions of polymer chain repeating units with thiol and acrylate moieties can be created
using the same approach and biocompatible reaction scheme. By varying the number of
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functional moieties, straight chain, branched and cross-linked compositions can be synthesized.
However, for in situ polymerization to be practical, gel times must be tunable across a range
from minutes to hours, which is easily achievable using this thiol-acrylate system. The strength
of these materials can also be manipulated by varying the initial DEA concentration, as the
functionality and cross-link density are both a function of the DEA concentration. This is caused
by the first Michael addition with the secondary amine, which results in the loss of an acrylate
functionality to the trifunctional acrylate. The 16.1% DEA concentration was chosen for further
analysis as a potential bone repair composite because it possessed the highest Young’s Modulus
and could be optimized to have a 15-20 minute gel time while forming a material with suitable
flexural strength. PETA was the most attractive acrylate in terms of biocompatibility and mass
loss data.
In Figure 2.1, the conversion of Alamar blue by PETA and PETA+HA polymers is
statistically the same as the tissue culture treated plastic and PCL control samples and similar to
other materials tested. The mass loss over a week of exposure to physiological solution is
represented in Figure 2.2.
Both PETA and PETA+HA demonstrated greater stability than other experimental
materials tested with similar losses to PCL. Greater physiological stability is considered an asset
in the proposed application as bone regeneration time is often on the order of weeks to
months.(van Gaalen et al., 2008) PETA containing polymers and composites degraded much
more rapidly than PETA, and the stability correlates with the molecular weight of the oligomer.
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While not explored in this study these polymers may have utility in other applications, such as
wound care, where rapid degradation may be seen as a positive attribute.
Biomimicry of the complex mechanical properties of native tissues proves elusive;
native tissue presents unique mechanical properties of nonlinear viscoelasticity and straindependent moduli.(Freed et al., 2009)

Figure 2.1 Relative metabolic activity of hASC in thiol-acrylate extractives as measured by
Alamarblue fluorescent conversion. Relative fluorescent units have been normalized to live
control. Asterisk indicates the sample is significantly different from dead control
The compressive strength of human cortical and cancellous bone are 130-180 MPa and 412 MPa, respectively.(Rezwan et al., 2006) The mechanical testing of solid/foam PETA-coTMPTMP materials is shown in Figure 2.3.
Additionally, it was found that the maximal compressive strength of this PETA-coTMPTMP+HA polymer at 90% strain is 19.23 ± 1.39 MPa while the pure PETA-co-TMPTMP
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polymer is 7.71 ± 0.09 MPa. This result indicated that the introduction of ceramics improves the
mechanical strength of the PETA copolymer similar to previously published results.(Hong et al.,
2008; Reynaud et al., 2001) The compressive strength of PETA-co-TMPTMP+HA foam is 0.72
± 0.07MPa while the pure PETA-co-TMPTMP foam is 0.14 ± 0.02MPa.

Figure 2.2 Mass loss after 7 days of incubation in stromal media. Samples are normalized to the
starting mass for each sample
The foamed polymer has decreased mechanical strength compared to the solid polymer
due to the large porosity. The mechanical properties of the copolymer polymerized in vitro, 0.84
± 0.05 MPa, and in situ, 0.85 ± 0.06 MPa, in physiological media were very similar, indicating
the presence of aqueous physiological media during the polymerization and foam structure
formation has little impact on morphology and mechanical properties.
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2.3.1 Mass balance
The polymer samples were extracted for 7 days in the stromal medium in order to
determine the extent of mass loss.
These extracts were later used in cytotoxicity testing. The copolymer-HA composite
foam and solid cast copolymer were found to have significantly greater mass loss than the PCL
control foam.

Figure 2.3 Compressive strength tested using hydraulic universal testing machine at an extension
rate of 0.5mm/min to a maximum compression strain of 90%.
The mass loss is believed to occur as a result of hydrolytic chain scission in a manner similar to
the degradation of PCL in physiological solutions.(Pitt et al., 1981) The PCL sample increased
in mass likely as a result of mineralization or non-specific protein deposition (Figure 2.4).
Similarly to PLLA and PGA, the degradation of PCL occurs by bulk or surface hydrolysis of
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ester linkages resulting in a byproduct of caproic acid.(Ahn et al., 2009) At high concentrations
of these degradation products, local tissue acidity may increase, resulting in adverse responses
such as inflammation or fibrous encapsulation.(van Gaalen et al., 2008)

Figure 2.4 Mass loss of foamed samples after 7 days of incubation in stromal media.
Samples are normalized to the staring mass of each sample.
2.3.2 Cytotoxicity test
PCL foam was fabricated by thermally induced phase separation from 1,4-dioxane followed by
lyophilization.(Zanetti et al., Accepted October 4, 2012)

Tissue culture treated polystyrene

served as a positive control, while ethanol treated hASC served as a negative control. Cells
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exposed to both the copolymer and copolymer+HA composite (solid and foam) extracts had
significantly higher metabolic activity than the dead control or cells exposed to the PCL extract
(Figure 2.5A). The reduction of hASC metabolic activity cultured on PCL does not correlate
with a significant mass loss (Figure 2.4), indicating that this reduction in activity is likely not
related to the generation of acidic PCL degradation products.
2.2.3 Biocompatibility test of hASC cells on the polymer
The ability of the PETA-co-TMPTMP polymer to support hASC cell adhesion and shortterm culture was evaluated using Alamar blue metabolic activity assays and SEM to examine cell
morphology. Cells were cultured on solid cast PETA and PETA-HA (20% wt/wt) composite
samples for 4 days in stromal media and assayed for fluorescent Alamar blue conversion; styrene
treated tissue culture plates served as a positive control. Compared to the positive control, hASC
cultured on both the copolymer and the copolymer-HA composite had significantly lower
metabolic activity (Figure 2.5B). Additionally, it appears that cells cultured on the copolymerHA composite have significantly lower metabolic activity than cells on the non-composite. This
may be a result of reduced metabolic activity associated with the differentiation of stem cells
exposed to HA, a known osteogenic compound, and may not be indicative of reduced
biocompatibility.(Rydholm et al., 2005) Based on Figure 2.5C, PETA foam demonstrates a
relatively higher metabolic activity than solid PETA-HA composite and PCL foam, but
significantly lower metabolic activity than cells on tissue cultured treated styrene. Although the
foam PETA copolymer has a much larger surface area than solid PETA copolymer, the results
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indicated that both forms of PETA copolymer supports hASC growth around the same level
compared to the positive control.

Figure 2.5 Relative metabolic activity of hASC as determined by Alamarblue conversion.
Asterisks indicate the sample is significantly different from live control. The results are
normalized to the live control. A: Exposure to 7 day stromal media extracts from PETA, PETAHA, and PCL foams and solids. B: Cultured on solid cast PETA and PETAHA composites. C:
hASC cultured on foamed PETA and PETA-HA composites.
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2.2.4 DNA quantification on scaffolds ( Picogreen assay)
DNA content of hASC cultured on all pure PETA, PETA composite, and PCL scaffolds
was compared as a relative measure of cell viability and proliferation. After 4 days, the highest
DNA content was observed in the PETA (20% HA) scaffold, 66.7% of the TCP control. The
relative DNA content of the pure PETA and PCL scaffolds are approximately 56% and 65% of
the live control respectively (Figure 2.6). The DNA content from cells cultured on all
experimental samples are similar indicating that the total number of cells does not vary
significantly with composition. This result is in contrast to the metabolic activity results (Figure
2.5a), which indicate a significantly reduced metabolic activity for cells grown on composite
PETA/HA samples. This further supports the hypothesis that these cells on PETA/HA are likely
in a reduced metabolic state as a result of early stage osteogenic differentiation.(Liu et al.,
2008b)

Figure 2.6 Relative total DNA amount as determined by picogreen assay for hASC
cultured on foamed PETA and PETA-HA composites. The results are normalized to the live
control. Asterisks indicate significant difference among the samples
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2.2.5 SEM analysis.
The PETA-co-TMPTMP foam materials were found to have a largely closed celled
structure with a pore size ranging from ~200-300 μm (Figure 2.7 right).

Figure 2.7 SEM image of PETA polymers in solid (left) and foamed (right) forms.
Magnification is ×100 with scale bars of 100µm
A comparative image of the cast solid copolymer of the same composition can be seen in
the left panel of Figure 2.7. The bubbles in the solid sample (Figure 2.7 left) are likely a result of
air introduced during the mixing procedure.
The size of the pores found in the foamed sample fall within the range of pores found in
native cancellous bone.(Hulbert et al., 1970) hASC morphology analysis was performed after
culturing the human ASC cultured for 7 days on the solid cast PETA films.
The cells were fixed and imaged by SEM in an effort to evaluate the morphology of
hASC on the thiol-acrylate copolymer.
From these images, it appears that hASC adhere well and take on the expected spindle
shaped morphology during culture on the thiol-acrylate copolymer films (Figure 2.8).
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It is likely the thiol groups impart a negative charge to the PETA co-polymer, potentially
increasing the adhesion, spreading, and proliferation of hASC cells on these surfaces compared
to neutral surfaces.(Kumar et al., 2010; Schneider et al., 2004)

Figure 2.8 SEM images of PETA solid cast polymer films (A&B) and hASC after culture for 7
days on PETA films. Magnification is ×100 (A&C) and×1000 (B&D), scale bars are 100 and
10µm, respectively.
At lower magnification (100×) (Figure 2.8C) a confluent cell population is seen
spreading more or less uniformly across the surface, while at higher magnification (1000×) the
aligned spindle shaped morphology of individual cells can be clearly seen (Figure 2.8D). Cell
free controls (Figure 2.8A&B) are included in this image for comparison.

SEM analysis

indicates that there is no substantial difference between the in vitro and in situ (20%HA) foamed
samples in terms of porosity and morphology (Figure 2.9A-D).
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Figure 2.9 SEM images of in vitro PETA-co-TMPMP þ HA foam (A&C) and in situ PETA-coTMPTMP+ HA foam (B&D). Magnification is ×100 (A&B) and×1000 (C&D), scale bars are
100 and 10 µm, respectively.
2.2.6 Micro-CT analysis
Micro-CT image data (Figure 2.10A-C) show good contrast between HA and polymer,
confirming suitability of micro-CT as an appropriate study the HA distribution and pore
morphology.

Figure 2.10 Micro Ct obtained orthogonal slices analyzed using Image J. Foamed PETA-coTMPMP with 0% HA (A), and in situ PETA-co-TMPTMP foam (B), in vitro PETA-co-TMPMP
foam (C) are all shown to have pore sizes ranging from 100 to 800 µm. The scale bar is 500 µm.
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Volume renderings (Figure 2.11A) were generated from PETA-co-TMPTMP foam 3D
data using Avizo 7.0.1 (Visualization Services Group).

Figure 2.11 Micro Ct obtained 3D data with two overlapping subvolumes rendered
simultaneously. Red–orange–white colormap corresponds to the PETA-co-TMPTMP foam, and
the blue–green corresponds to HA inclusions. A: 0% HA foamed. B: In situ foamed 20% HA. C:
In vitro foamed 20% HA.
Figures 2.11B (in situ) and Figure 2.11C (in vitro) were generated from PETA-co-TMPTMP
with 20%HA foam 3D data. Two overlapping sub-volumes are rendered simultaneously, one
with a red-orange-white colormap corresponding to thiol-acrylate foam, and the other with a
blue-green colormap corresponding to hydroxyapatite inclusions.
Volume renderings indicate open-cell foam and interconnectivity.

By providing an

interconnected pore structure the support of cell migration, differentiation, nutrient support (Di
Maggio et al., 2011; Lawrence & Madihally, 2008) and in some cases, the formation of blood
vessels (Mehrkens et al., 2009; Papadimitropoulos et al., 2011; Scherberich et al., 2007) can be
established. HA inclusions with the size of 10-50 microns were aggregated showing that a higher
torque and speed of the stirrer are needed to achieve better homogeneity. Measurements using
NIH ImageJ from these datasets indicate pores ranging from 100-500 microns for control (0%
HA) and 20% HA having 125-800 microns.
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2.3 Conclusion
The step growth nature of the amine catalyzed Michael addition reaction alleviated the
concern of unreacted monomer or radicals leaching into the body as would typically occur using
a chain-growth mechanism involving a free-radical process. In situ polymerization opens the
opportunity for the development of absorbable foams for the conformal repair of critical sized
tissue defects, which can be easily delivered in the clinical surgical setting. This represents a
substantial improvement over PCL, which are foamed externally prior to surgical insertion, and
methylmethacrylate bone cements, which are largely inert, non-porous, and permanent. The
SEM analysis, mechanical testing, and micro CT data prove that there is no distinct difference
between the PETA-co-TMPTMP foam made in situ and in vitro. While this material has many
advantages, future work includes the development of a homogenous HA containing polymer
network, osteogenic studies and improved mechanical strength of the foamed PETA-coTMPTMP with varying HA amounts. It is clear that scaffold technology plays a critical role in
the success of the current stem cell based bone tissue engineering paradigms. While a variety of
different materials, both ceramics and polymers, have been tested in combination with hASC,
Lendeckel et al. and others note that composite scaffolds may offer a better clinical outcome as a
result of improved mechanical and biological properties.(Lendeckel et al., 2004) Calcium
phosphate nanoscale ceramic particles of HA and β-TCP will be used as the inorganic osteogenic
phase and thixotropic agent in future studies.
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CHAPTER 3 IN VITRO AND IN VIVO CHARACTERIZATION OF
PENTAERYTHRITOL TRIACRYLATE-CO-TRIMETHYLOLPROPANE
NANOCOMPOSITE SCAFFOLDS AS POTENTIAL BONE AUGMENTS AND
GRAFTS2
3.1. Introduction
For the past several decades, the standard treatment to augment or accelerate bone
regeneration has been the implantation of bone grafts. (Pallua & Suscheck, 2010a) Allogeneic
bone grafts are costly, require time-consuming bone banking procedures, and have the potential
for disease transmission. Autogenous bone grafts have long been used as bone replacements but
require additional surgeries, which increase the risk of donor site morbidity and the burden on
health care providers. (Ahlmann et al., 2002) Moreover, these techniques do not address the need
for a clinically convenient and biodegradable method for conformally filling a critical sized bone
defect while providing mechanical support and biological cues necessary to promote bone
regrowth. Artificial composite scaffolds, whether bioderived, synthetic or hybrids, while studied
extensively as alternatives for bone grafting and augmentation, have yet to see wide clinical
adoption. (Zanetti et al., 2013b)

Composite structures with calcium phosphates and

magnesium silicates composing the bioactive ceramic portion, have been studied thoroughly to
improve both the mechanical and osteogenic properties of scaffolds but an in situ polymerizing
biodegradable bone augment or graft with biomimetic morphology and mechanical properties
remains elusive. (Bohner, 2010; Hutmacher, 2000; Zanetti et al., 2013b) An initial study
conducted by our group demonstrated the formation of a porous interconnected scaffold derived
from the product of an amine-catalyzed Michael addition polymerization reaction.(Garber et al.,
2013a) This thiol-acrylate reaction proceeds through a non-radical, step-growth process initiated

2

Reprinted with the permission of Tissue Engineering Part A (Appendix B)
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by an amine/acrylate co-monomer which is consumed in the reaction and incorporated into the
growing polymer. Porous composite scaffolds made with this system were found to support
human mesenchymal stromal/stem cell growth and to possess similar mechanical properties to
cortical bone. (Sundelacruz & Kaplan, 2009)

The fabrication method of a scaffold can have a substantial impact on mechanical properties
and bio-functionality by controlling porosity and interconnectivity. These factors influence cell
attachment, proliferation, extracellular matrix production, and the transport of nutrients and
wastes. (Degasne et al., 1999; Karageorgiou & Kaplan, 2005; Levine, 2008; Singh et al., 2009;
Zanetti et al., 2012b) Solid freeform fabrication, thermal precipitation, gas foaming, and solvent
casting followed by particulate leaching are the common approaches for making porous scaffolds
for bone repair. (Karageorgiou & Kaplan, 2005; Levine, 2008) Except for gas foaming, these
methods are not readily applicable to thermoset polymers due to their cross-linking densities and
viscoelastic properties. Gas porogens and foaming apparatuses have the potential to be readily
adapted to filling conformal defects in a clinical environment, similar to other surgical devices in
use, such as fibrin sealant (Topart et al., 2005; Yeh & Tucker, 2005) and bone putty. (Gertzman
& Sunwoo, 2000)

Herein we report on the in vitro characterization of the mechanical and osteoinductive
properties of a gas foamed nanocomposite scaffold consisting of a thiol-acrylate copolymer with
nanoscale hydroxyapatite (HA) inclusions. Scaffolds were prepared using a gas phase propellant
and foaming agent to investigate the relationship of scaffold composition to morphology,
mechanical properties, cytocompatibility, and osteogenic properties. The impact of varying HA
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concentration in the PETA polymer on morphology is illustrated using SEM and micro-CT
imaging. Mechanical testing was conducted to determine the compressive yield strength and
modulus of the material. To evaluate cytocompatibility and osteogenic activity, human adipose
derived mesenchymal stromal cells (hASC) were used as a model cell type. Metabolic activity,
DNA content, calcium deposition, and the expression of the osteogenic markers alkaline
phosphatase (ALP) and osteocalcin (OCN) were quantified with respect to scaffold composition.
A six-week in vivo study was also conducted to assess the basic biocompatibility of the foamed
composite and the feasibility of in situ foaming for a boney fusion model.

3.2 Materials and Methods

3.2.1 Preparation of thiol-acrylate materials
All chemicals were used as received: Trimethylolpropane tris(3-mercaptopropionate)
(TMPTMP) was obtained from Aldrich, diethylamine (99% purity) (DEA) from AGROS
organics, and pentaerythritol triacrylate from Alfa Aesar.
Scaffolds were prepared by formulating PETA with 16.1% DEA and adding TMPTMP in
a 1:1 molar functionality ratio, followed by mixing with a stir rod for 3 hours as previously
described.(Garber et al., 2013a) Several concentrations of copolymer PETA with HA were
studied, the first number in the abbreviation connotes the polymer content while the second
number provides the amount of HA found in the composite as a wt/wt percentage (100:0, 85:15,
80:20, 75:25). The mixtures were cast into cylindrical molds (510 mm) to form a solid scaffold.
The foamed composite copolymer was prepared by pouring the PETA and HA (150 g in total)
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into a 250 mL pressurized canister using 7 g-compressed nitrous oxide as a gas foaming agent.
The foamed composite copolymer was expelled into the same cylindrical molds used for solid
casting.
3.2.2 Mechanical testing
Solid and foamed scaffolds, molded to 6mm (diameter)×12mm(height) cylinder shape,
were tested to determine maximal compressive strength and modulus. All scaffolds, solid, gas
foamed or thermally precipitated, were subjected compression, and the ultimate compressive
strength was reported at 30 percent strain. A universal testing machine (Instron Model 5696,
Canton, MA, USA) was used at an extension rate of 0.5 mm/min.(Garber et al., 2013a)
3.2.3 Morphological analysis
All of the scaffolds were placed on the EMS550X sputter coater, which applied a
conductive platinum coating for 4 minutes followed by standard SEM analysis. Human cadaver
bone from knee area was obtained under LSU exempted IRB protocol HE 13-10 from the LSU
Health Science Center.
3.2.4 Micro-CT analysis
Four PETA:HA (100: 0), (85:15), (80:20), (75:25) foams were fabricated by pressurized
extrusion foaming and prepared as previously described.(Garber et al., 2013a) The imaging was
conducted at the Center for Advanced Microstructures and Devices (Louisiana State University,
Baton Rouge, LA) using a tomography beamline with 13 keV monochromatic x-rays with a 2.5
μm/px resolution. Projection exposure time varied from 2-4 seconds with Δθ=0.25 corresponding
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to the number of image slices (520). Reconstruction data were 16-bit signed integer with mean
air intensity scaled to zero.
Avizo 7.0.1(Visualization Services Group) generated the volume renderings from the 3D
data of the four foamed samples with two overlapping sub-volumes displayed simultaneously.
The blue-green colormap represents the hydroxyapatite inclusions, and the red-orange colormap
represents the copolymer foam. Image J generated 2-D orthogonal slices possessing grey
colormap settings using the same data with a scale equivalent to the 3-D rendering. An
approximate pore size was also measured using Image J. The orthogonal and micro-CT datasets
were directly comparable, both as an aggregate dataset and as slices.
3.2.5 Porosity calculation based on micro-Ct
To analyze the three-dimensional data, two dimensional slices were read into a custom
MATLAB code. For each slice the grayscale image was thresholded using Otsu’s method (Otsu,
1975) and then converted into a binary image. Morphological operations were performed to
remove small imaging artifacts, and isolate interior and exterior pores. After quantifying solid
and void pixels, porosity was calculated as follows:

3.2.6 Adult stem cells isolation and culture
Liposuction aspirates from subcutaneous adipose tissue were obtained from three healthy
adult subjects (male = 1 and females = 2) undergoing elective procedures. All tissues were
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obtained with informed consent under a clinical protocol reviewed and approved by the
Institutional Review Board at the LSU Pennington Biomedical Research Center and used under
an exempted protocol at LSU A&M College.

Isolation of hASC was performed as

published.(Zanetti et al., 2012b) Passage 2 of each individual was used for in vitro hASC
osteogenesis evaluation on tissue culture treated plastic or on scaffolds of different compositions.
In both cases, hASC were cultured in either stromal (control - DMEM, 10% FBS, and 1% triple
antibiotic solution) or osteogenic (DMEM, 10% FBS, 0.1 μM dexamethasone, 50 μM ascorbate2-phosphate, 10 mM β-glycerophosphate, and 1% triple antibiotic solution) media for up to 21
days with media maintenance performed three times a week.
3.2.7 hASC loading on scaffolds and culture
All types of scaffolds were either molded or sculpted into 5 mm(diameter)×10mm(height)
cylinder shape and gas sterilized afterwards. All the scaffolds were then submerged in stromal
medium for 1hour before loading the hASCs. The same amount of second cell passages from all
donors (n = 3) were pooled and directly loaded on a single face of each scaffold type at a
concentration of 1.0 × 104 cells/µL for total volume of 5 µL. After 30 min of incubation in a
saturated humidity atmosphere incubator at 37 °C and 5% CO2, the same volume of hASCs
containing solution were directly applied on the opposite side of each scaffold as previously
described. (Zanetti et al., 2012b) Control groups included PCL:HA (100:0 and 80:20) scaffolds.
Experimental groups included PETA:HA (100:0, 85:15, 80:20, 75:25) scaffolds. Scaffolds
loaded with hASC were immediately transferred to 48-well plates and cultured in stromal or
osteogenic media for 21 days. Cell medium were changed every 2-3 days. Triplicates were
performed for each assay.
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3.2.8 In vitro hASC metabolic activity on scaffolds
AlamarBlueTM (Life Technologies) is a useful measure of metabolic activity and is frequently
used as an analog of cell viability and proliferation. All scaffold samples were seeded with hASC
and cultured in stromal or osteogenic media for 21 days. The AlmarBlueTM conversion was
measured at 7, 14, and 21 days The scaffolds were removed from culture, washed three times in
Phosphate Buffered Saline (PBS), and incubated with 10% Alamar Blue™ in Hank’s balanced
salt solution (HBSS) without phenol red (pH 7) for 90 min. The ﬂuorescence of three aliquots
(100 L) from each scaffold were measured at an excitation wavelength of 530 nm and an
emission wavelength of 595 nm using a ﬂuorescence plate reader (Wallac 1420 multilabel hts
counter).
3.2.9 Alizarin red staining
hASC calcium deposition (triplicates of scaffolds alone and cell-scaffolds) was assessed after
7, 14, and 21 days of culture in control or osteogenic medium based on alizarin red staining.
Wells were washed with 0.9% NaCl and ﬁxed with 70% ethanol. Wells were stained with 2%
alizarin red for 10 minutes and washed with DI water.

Wells were destained with 10%

cetylpyridinium chloride monohydrate for 4 hours at room temperature with constant agitation.
Results were normalized to values from scaffolds cultured without cells for the same time
periods.
3.2.10 In vitro quantification of DNA on scaffolds
Total DNA content was used to determine the number of cells on each scaffold as previously
described.(Liu et al., 2008a) After triplicates of each scaffold were minced by a scalpel and the
DNA was digested with 0.5 mL of 0.5mg/mL proteinase K (Sigma-Aldrich) at 56 ºC overnight,

53

aliquots (50 µL) were mixed with equal volumes of 0.1 g/mL

Picogreen dye solution

(Invitrogen) in 96-well plates. Samples were then excited at 480 nm with a plate reader (Wallac
1420 multilabel hts counter). Scaffolds without cells were used as negative controls.
3.2.11 Quantitative real-time polymerase chain reaction (QPCR)
Total RNA was extracted from triplicates of cell-scaffold constructs as previously
described.(Zanetti et al., 2012b) Total RNA to cDNA EcoDry Premix (ClonTech) for cDNA
synthesis.

qRT-PCR was performed using 2× iTaqTM SYBR® green supermix with ROX

(Biorad) and primers for alkaline phosphatase (ALP) and osteoscalcin (OCN)(Zanetti et al.,
2012b) to quantify osteogenic target gene expression of hASC loaded to scaffolds and cultured in
either stromal or osteogenic media for 7, 14, and 21 days. Reactions were performed with a MJ
MiniTM Thermal Cycler (BioRad). The sequences of PCR primers (forward and backward, 5030)

were

as

follows:

ALP,

5’-AATATGCCCTGGAGCTTCAGAA-3’

CCATCCCATCTCCCAGGAA-3’;OCN,

5’-GCCCAGCGGTGCAGAGT-3’

and
and

5’5’-

TAGCGCCTGGGTCTCTTCAC-3’.Samples were normalized (ΔCt) against the house keeping
gene 18S rRNA and the - ΔΔCt value of ALP and OCN in scaffolds cultured in osteogenic and
control media was calculated using the ΔΔCt method.(Livak & Schmittgen, 2001b)
3.2.12 Statistical analysis
All results were expressed as mean ± SEM. Data was analyzed with one-way analysis of
variance (ANOVA), followed by Tukey’s minimum significant difference (MSD) post hoc test
for pairwise comparisons of main effects. For all comparisons, a P-value < 0.05 was considered
significant.
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3.2.13 In vivo study
Scaffold Preparation and Surgical Implantation
Five male Fischer rats (Harlan Sprague-Dawley, Indianapolis, IN) were randomly assigned
to three different treatments: (1) 1 rat was implanted with pre-sculpted PETA+20% HA, (2) 3
rats were implanted with PETA+20% foamed in situ, or (3) 1 rat was implanted with PETA+0%
HA foamed in situ Stock/HA and TMPTMP/HA pre-polymer mixture were placed into a 250 mL
pressurized spray canister with 7 g-compressed nitrous oxide as a gas foaming agent. The
foamed composite copolymer was expelled from the canister onto a sterile surface.

The solid

composite was cut into a rectangle with dimensions (15 mm×10 mm×1 mm) for rat number 1.
For rats 2, 3, and 4, the pre-polymer mixture was prepared as described above and foamed into a
5 mL syringe for surgical application. The process was the same for rat 5, but the formulation
did not contain HA.

The rat posterolateral lumbar spinal fusion surgery was performed as

previously described (Aust et al., 2004).

Prior to general anesthesia, rats received a

subcutaneous injection of 0.5 mg/kg butorphanol (Torbugesic, Fort Dodge Animal Health) and
0.02 mg/kg glycopyrrolate (Robinul-V, Fort Dodge Animal Health, Fort Dodge, IA). Isoflurane
was administered 20 minutes later in an induction chamber to induce anesthesia. The isoflurane
was maintained at 1.5% via nose cone on a Bain circuit for the remainder of the procedure. The
lumbar region was clipped and aseptically prepared with 70% isopropanol and betadine. A
posterior midline skin incision was made over the lumbar spine. Two fascial incisions were made
3 mm lateral and parallel to the dorsal spinus processes. The L4 and L5 transverse processes
were exposed with sharp and blunt dissection. A scalpel was used to decorticate each transverse
process. Surgical sites were thoroughly lavaged with physiologic saline. In rat 1, solid scaffolds
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were placed adjacent to both sides of the spine such that they spanned between the midpoint of
each transverse process. For the remaining rats, 3 ml of each foamed scaffold was applied so that
scaffold spanned between the center of each transverse process next to the spine. Fascial and
subcutaneous incisions were closed separately with 3-0 polyglactin 910 (Vicryl, Ethicon) in a
simple continuous pattern. Closure of the fascia around the implants effectively filled any
potential space. A subcutaneous/subcuticular suture pattern was used to approximate skin edges,
and tissue adhesive was used for skin closure (Vetbond, 3M). Scaffolds were harvested 3 (rat 3)
or 6 (rats 1,2,4,5) weeks after implantation following euthanasia by CO2 asphyxiation (Lopez et
al., 2009). At 3 weeks, no significant results were shown in radiographs, micro-CT or histology
analysis. Therefore, no results from Rat 3 were reported in the results and discussion sections.
Micro-CT Analysis
Immediately postmortem, two-dimensional (2-D) microcomputed tomography (μ-CT)
imaging was performed (40 kV and 540 ms) to obtain 0.04 mm slices every 0.9°throughout a
360° rotation (SkyScan 1074, Skyscan n.v., Belgium). Three-dimensional (3-D) files were
reconstructed from 2-D images. Measurements of 2-D and 3-D images were performed with
AVIZO® Standard packages (FEITMVisualization Sciences Group). A density line was first
drawn in void space with no tissue to measure the optical density (OD) of the image background.
The line was then moved to L3 of the specimen’s vertebral column to determine the OD of the
tissue unaffected by the surgery. Lastly, the density line was moved between L4 and L5 of the
specimen’s vertebral column to calculate the OD of the area treated by the scaffolds. The density
of the area treated by the implant was normalized by the densities of the void space and the
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unaffected bone region in order to calculate the percentage of bone growth present in each
specimen (Lopez et al., 2009).
255

𝑂𝐷 = log 𝑃𝑖𝑥𝑒𝑙 𝑣𝑎𝑙𝑢𝑒

𝑂𝐷𝑇𝑟𝑒𝑎𝑡𝑒𝑑
𝑂𝐷𝑈𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑

× 100 = % 𝑛𝑒𝑤 𝑔𝑟𝑜𝑤𝑡ℎ

Histology
Following imaging, spines were cut in half and fixed in neutral buffered formalin. One
half of each spine was decalcified, paraffin embedded and longitudinal sections (5 um) were
stained with hematoxylin and eosin. Microarchitecture was evaluated using Olympus BX46
microscope.
3.3. Results
3.3.1. SEM analysis
The foamed scaffold samples were analyzed using SEM to examine the trends in
morphology. The morphology of the foam containing 0-20% HA was similar to cancellous
human cadaver bone (Figure 3.1).

Figure 1 SEM analysis of PETA:HA (100:0), (85:15), (80:20), (75:25) scaffolds
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The average pore diameters of PETA: HA 100:0 and 85:15 scaffolds were 250µm300µm, with no significant difference between the two. PETA:HA 80:20 had a slightly smaller
pore diameter of 150µm-200µm. The pore diameter of PETA:HA 75:25 was only 70µm-100µm.
PETA:HA 70:30 had a pore diameter of less than 50µm. It is apparent from the results in Figure
3.1 that pore size is inversely related to HA content; pore diameter decreases as HA
concentrations increase. Additionally, increasing HA content correlates with increased pore wall
thickness and an apparent reduction in scaffold interconnectivity.
3.3.2. Micro-CT analysis and porosity calculation
There is a limitation associated with the amount of material that SEM can qualitatively
analyze, reducing the generalizability of the data. To address this limitation, the interconnectivity,
pore volume, and ceramic phase distribution of HA-PETA copolymer composites and PCL
(control) were further analyzed by micro-CT. Micro-CT image analysis is a more senstivie
method for estimating porosity of materials when compared to SEM, flow porosimetry, and gas
adsorption. (Ho & Hutmacher, 2006) Volume renderings (Figure 3.2) were generated from
PETA and PCL composite foam 3-D data using Avizo 7.0.1 (Visualization Services Group).
Two overlapping sub-volumes were rendered simultaneously, one with a red-orange-white
colormap corresponding to thiol-acrylate foam, and another with a blue-green colormap
corresponding to hydroxyapatite additives. The porosity of PETA: HA (100:0, 85:15, and 80:20)
are 66.9%, 72.0%, and 66.4% respectively (Figure 3.3A). It should be noted that an apparent
transition in morphology occurred between 20% and 25% HA inclusions. As HA concentration
increased from 20% to 25%, the porosity decreased significantly from 66.4% to 44.7%. When
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HA concentration reaches 25%, the pore size is substantially reduced and the interconnected void
volume appeared to decrease, resulting in a structure similar to a closed-cell foam (Figure
3.2K&L).

Figure 2 Avizo rendering pictures (3D &2D) of micro-ct data of scaffolds. Figure 2A&B
PCL:HA (100:0); Figure 2C&D PCL:HA (80:20) ;Figure 2E&F PETA: HA (100:0) Figure
2G&H PETA: HA (85:15) scaffolds; Figure 2I&J PETA: HA (80:20) scaffolds; Figure 2K&L
PETA: HA (75:25) scaffolds. Each scale bar in the 2D pictures indicates 500µm.
This is attributed to increased polymer solution viscosity correlated with reduced N2O
expansion and mobility. In addition, the inclusion of 20% HA to PCL scaffolds increased the
porosity from 78.0% (PCL:HA 100:0) to 87.6% (PCL:HA 80:20) (Figure 3.2A&C).
3.3.3. Mechanical testing
Figure 3.3B shows the compressive yield strength of the foamed and solid PCL:HA (100:0,
80:20), PETA:HA (100:0, 85:15, 80:20, 75:25) samples.
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Compressive strength of solid PCL:HA (100:0, 80:20) samples are significantly higher
than corresponding PETA:HA (100:0, 80:20) samples. When comparing among porous scaffolds,
PETA:HA (100:0, 80:20) scaffolds are either the same as or stronger than PCL:HA (100:0,
80:20). The compressive strength of the foamed PETA:HA steadily increased with increasing
HA content; however, the solid samples did not follow a similar trend. The addition of 15% HA
in the foam resulted in a significant increase in compressive strength compared to the control
samples and increasing the HA content beyond 15% correlated with increased compressive
strength.

Figure 3 porosity of PETA:HA (100: 0), (85:15), (80:20), (75:25) scaffolds; B: maximum
compressive strength of PETA:HA PETA:HA (100: 0), (85:15), (80:20), (75:25)
composites(solid and foam)
Conversely, solid PETA:HA (85:15, 80:20, 75:25) composite scaffolds exhibited
approximately the same compressive strength for all HA containing samples. It is believed that
the porosity (Figure 3A) is responsible for the different trends between solid and foamed
scaffolds.
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3.3.4. hASC metabolic activity and proliferation on scaffolds cultured in control and
osteogenic media
For cell-scaffold constructs cultured in stromal media, PETA:HA (100:0) had the highest
metabolic activity after 14 days of culture. PCL:HA (100:0) had the highest levels of metabolic
activity after 21 days of culture in stromal medium and no significant differences were observed
from this scaffolds between any time point. In osteogenic media, PETA:HA (100:0) scaffolds
again exhibited the highest metabolic activity after 7, 14 and 21 days of culture. PETA:HA
(85:15 and 80:20) scaffolds had the next highest metabolic activity at all time points. PCL
scaffolds showed the lowest levels of metabolic activity after 7, 14 and 21 days of culture
(Figure 3.4A). The addition of HA to PETA and PCL scaffolds decreased metabolic activity on
constructs cultured in stromal and osteogenic media.
Significantly higher metabolic activity in was observed at all-time points for PCL:HA (100:0)
and PCL:HA (80:20) scaffolds cultured in stromal media compared to osteogenic media. This
data is in agreement with previous studies which indicate the metabolic activity of hASC is
expected to decrease as cells commit to an osteogenic linage.(Qureshi et al., 2013; Zanetti et al.,
2012b)
No differences in metabolic activity were seen in PETA:HA composite samples between
stromal and osteogenic conditions. hASC cultured on HA-containing scaffolds were expected to
begin differentiation into an osteogenic linage regardless of the media condition, potentially
accounting for the differences in metabolic activity between HA-containing and control samples
with respect to media condition. Almost no metabolic activity was measured in PETA:HA (75:25)
scaffolds, likely as a result of the reduced pore size and interconnectivity.
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Figure 3.4 Panel A: relative metabolic activity of hASC on PETA:HA (100:0), (85:15), (80:20),
(75:25) scaffolds; Panel B: relative DNA content of hASC on PETA:HA (100: 0), (85:15),
(80:20), (75:25) scaffolds; Panel C: q-rtPCR analysis of ALP (7 day) and OCN (14 and 21 day)
expression from hASC on PETA:HA (100:0), (85:15), (80:20), (75:25) scaffolds.
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Total DNA content was quantified using Quant-iT™ PicoGreen ®, to analyze the hASC
proliferation in scaffolds. Differences in DNA content, between stromal and osteogenic media
conditions, were observed at the 7 day culture time point for PCL:HA (80:20), PETA:HA (85:15)
and PETA:HA (80:20) composite scaffolds. When comparing samples within the stromal media
treatment condition, it can be observed that the PETA:HA samples had significantly fewer cells
than the PCL or PETA control. The most pronounced difference in DNA content was between
PCL:HA (80:20) composites and PETA:HA scaffolds in stromal media conditions, (Figure 3.4B)
where the DNA content in PCL (80:20) scaffolds was significantly higher than PETA:HA
composites. At 14 and 21 days, levels of DNA content observed in both PCL scaffolds and the
pure PETA scaffolds were significantly higher than the PETA:HA composites, in stromal media
conditions. Within the osteogenic media treatment groups, the PETA:HA scaffolds showed
slightly increased DNA content compared with the PCL:HA scaffolds, but all scaffolds
contained a similar numbers of cells.
3.3.5. Quantitative real-time polymerase chain reaction (QPCR)
Bone morphogenic proteins (BMPs), known to regulate osteogenesis, act on the transcription
factor core binding factor alpha1 (Cbfa1) and result in the activation of osteoblast-related genes,
such as ALP and OCN. (Liu et al., 2008a; Milat & Ng, 2009) The expression of these genes are
commonly used as early and middle stage markers of osteogenesis, respectively.(Burge et al.,
2007) QPCR was used to assess the expression of ALP at the 7 day time point and OCN at 14
and 21 day time points (Figure 3.4C). Based on previous studies, ALP expression in hASC
decreased dramatically after 7 days in culture and was therefore not measured at the 14 and 21
day time points in this study.(Burge et al., 2007; Zanetti et al., 2012b) The differences in the
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expression of ALP and OCN in hASCs cultured on scaffolds in stromal and osteogenic media are
represented in Figure 3.4C. The cells on PETA:HA (85:15) and PETA:HA(80:20) scaffolds
showed similar expression of ALP at 7days and were significantly higher than all other PETA
and PCL scaffolds. Additionally, hASC on pure PETA scaffolds had higher ALP expression than
pure PCL control scaffolds. While hASC cultured on PCL:HA(80:20) scaffolds had higher ALP
expression than pure PETA or PCL, the expression was still lower than PETA:HA (85:15) and
PETA:HA(80:20) scaffolds. Moreover, the expression of the OCN marker could only be
observed at 21 days of culture, with little expression at 14 days regardless of treatment. The OCN
expression level demonstrated in hASC as a function of scaffold type was the similar to that of
ALP expression with maximal OCN expression observed in PETA:HA (85:15) and
PETA:HA(80:20) followed closely by OCN levels in PCL:HA composites. Consistent with the
previously described results, cells cultured on the PETA:HA (75:25) sample did not demonstrate
substantial expression of either marker, likely the result of poor cell proliferation/survival
associated with the lack of a porous and interconnected structure.
3.3.6 Calcium deposition in hASC cultured in control and osteogenic media
The mineralization of different scaffold types was assessed using alizarin red staining, which
stains calcium-rich deposits. hASC cultured on the PETA composites in stromal and osteogenic
media were tested against PCL and PCL:HA scaffolds. (Figure 3.5A)
As expected, alizarin red staining was significantly higher in hASC cultured in osteogenic
media compared to samples cultured in stromal media. (Zanetti et al., 2012b) Also, hASC
cultured in osteogenic media showed a significant increase in staining with respect to increased
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time in culture. Except for PETA:HA (75:25), all scaffolds showed significant differences in the
calcium deposition at 14 days between stromal and osteogenic media.

Figure 3.5 Alizarin red stain of PETA:HA as a function of scaffold composition, media
treatment and time. Panel A, quantitative analysis of staining on scaffolds loaded with hASC and
cultured in stromal and osteogenic media for 7, 14 and 21 days. Panel B, cross section of each
type of scaffold stained with alizarin red on 21 days.
Both PETA: HA (80:20) and PETA:HA (85:15) cultured in osteogenic media
demonstrated significantly increased staining compared to all other experimental samples and
controls. Almost no calcium deposition, however, was observed at 14 and 21 day culture time
points in PETA:HA (75:25).
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3.3.7 In vivo study
Radiography
Observed behavior and weight gain were normal (90.7 ± 5.9 g) for all rats after surgery.
Foamed thiol-acrylate nanocomposite implants showed some increase in radiographically
detectable opacity 3 weeks after implantation compared to immediately after surgery, and the
opacity increased further by 6 weeks after implantation. The increasing intensity of bone
scaffolds is consistent with scaffold calcification (Figure 3.6). Rats implanted with pre-molded
samples, had a lower increase in radioopacity by 6 weeks after implantation compared to rats
implanted with PETA+HA foamed in situ.

Figure 3.6 Radiographs of in vivo study
No evidence of calcification was observed in implants of 0% HA pre-sculpted PETA.
This is consistent with the in vitro osteogenesis target gene expression results.
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Microcomputed Tomography
The micro-CT results support the radiographic findings. The light colored regions
indicate densification in the scaffolds in Figure 3.7. In vivo, in situ polymerized scaffolds had
the greatest amount of densification six weeks after surgery.

Figure 3.7 Micro-CT data of the L4 (top) and L5 (bottom) vertebral bodies from the in vivo study.
The light colored regions indicate densification in scaffolds.
Analysis of Bone Formation using histology
Histological examination was performed on pre-sculpted PETA:HA (80:20), PETA:HA
(80:20) foamed in situ, and PETA:HA (100:0) foamed in situ. The essential step of decalcifying
and staining the spinal column poses a problem in analyzing tissues for bone formation
evaluating the calcified areas. For this reason, tissue morphology is considered a reliable
parameter to measure bone formation(Schulte et al., 2013). Each cohort was examined six weeks
post-op.
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Treatment cohort 1 (pre-sculpted PETA:HA (80:20)proved to be biocompatible, support
cell growth, and induce osteogenesis in tissue growing into the foam structure. Figure 3.8A
shows that the PETA:HA (80:20) implant is partially demarcated by fibrosis and multifocal
fibrocartilage formation, which incorporates multifocal, small areas of endochondral ossification.
Figure 3.8D contains the implant surrounded by fibrous tissue, fibrocartilage, and
peripheral endochondral ossification. The appearance of cells chondrocytic in appearance, a tide
mark, and an ossified site present around the implant site indicate that the PETA:HA (80:20)
scaffold have the potential to induce endochondral ossification.

Figure 8 Histology analysis using Hematoxylin and eosin staining. A medial cut was made on the
spinal column of each rat. The progress of this specimen guides the analysis of the other
specimens. Figures 8A, 8B, 8D, 8F, and 8I: Rat was treated with the pre-sculpted PETA:HA
(80:20) scaffold. Figure 8C, 8E, and 8G: Rats were treated with PETA:HA (80:20) scaffold
foamed in situ. Figure 8H: Rat was treated with PETA:HA (100:0) foamed in situ. S: scaffold
implants; *: site endochondral ossification
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Figure 3.8B shows that the polymer implant is segmentally demarcated by fibrous and
fibrocartilagenous tissues with an ossified rim blending into pre-existing trabecular bone. The
findings in Figure 3.8B are further supported by Figure 3.8I and Figure 3.8F.
Treatment 2 (PETA:HA 80:20 in situ) was also shown to be biocompatible, support bone
growth, and induce osteogenic differentiation. In cohort 2, histological changes are characterized
by ostegenic activity around the implant site. Figure 3.8C shows a large accumulation of polymer
implant near the skeletal muscle of the rat, surrounded by a thin layer of fibrous tissue with a
focal area also containing macrophages. Figure 3.8E shows the presence of a cavitation lined by
1-3 layers of spindled cells (fibroblasts) containing the scaffold and a sprouting nidus of
endochondral ossification. Figure 3.8G shows that in the area adjacent to the polymer-occupied
cavitation, there are fibrous tissues and a region of endochondral ossification.
Histological analysis of cohort 3 PETA:HA (100:0) indicates that the lack of nanoscale
HA reduces the osteogenic properties of the scaffolds. In Figure 3.8H, the scaffold is surrounded
by a very thin layer of fibrous tissue, indicating a reduction in the formation of organized tissue
in the implant region.
3.4. Discussion
Bone tissue engineering involving polymer/ceramic composites presents an attractive
alternative approach to the repair and regeneration of damaged or traumatized bone tissue.
(Gaalen et al., 2008; Pallua & Suscheck, 2010b). Several studies have previously explored the
potential use of thiol-acrylate chemistry for biomedical devices, but radical based photoinitiators
are usually used to drive the polymerization process.(Rydholm et al., 2008; Rydholm et al., 2006;
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Zanetti et al., 2012b) A non-radical based polymerization method is potentially less cytotoxic
and therefore more amenable to in situ polymerization. The amine catalyzed Michael addition for
thiol-acrylate polymerization described in this study has potential advantages compared to
photoinitiated reactions because the chain propagation does not require a free radical initiator
during the polymerization reaction. The mechanism of this amine-catalyzed reaction has been
previously investigated.(Bounds et al., 2013; Garber et al., 2013a) The general reaction occurs
via the formation of a catalyst/comonomer molecule by the Michael addition of a secondary
amine across the alkene end group found in acrylate monomers. The in situ catalyst produced
reacts with a trifunctional thiol and trifunctional acrylates forming a high-density cross-linked
copolymer. The step growth nature and the incorporation of the tertiary amine catalyst reduce
concerns about potential leaching of free radical initiators and unreacted monomer. This reaction,
therefore, is potentially more attractive for in situ polymerization for bone formation than
comparative free radical-based methods.
The PCL-based scaffold was synthesized via a thermal precipitation method resulting in
pore size, volume, and interconnectivity that are largely independent of solution
viscosity.(Qureshi et al., 2012) Results showed that such characteristics were directly influenced
by the viscosity of the stock solution in the polymerization of PETA composites. (Barby & Haq,
1985). It is well documented that an interconnected pore structure can help support cell
migration, cell differentiation, nutrient transport (Di Maggio et al., 2011; Lawrence & Madihally,
2008) and, in some cases, formation of blood vessels. (Mehrkens et al., 2009; Papadimitropoulos
et al., 2011; Scherberich et al., 2007) Because HA was found to decrease interconnectivity, it
was expected that the highest HA concentration sample, PETA:HA (75:25), would not provide a
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suitable environment for cell in-growth and nutrient/waste transport. Electron microscopy
images and micro-CT analysis indicate PETA:HA (75:25) scaffolds lack interconnectivity of the
void volume providing for cell penetration and nutrient/waste transport required for cell growth
and differentiation. The analysis of cell viability and expression of osteogenic markers further
supported this hypothesis.
The decreased metabolic activity of PETA:HA composites compared to the PETA control is
likely related to differences in cell function, not cell number, attributed to osteogenic
differentiation of hASC. The decreased cell proliferation and metabolic activity also had an
inverse relationship with the increased calcium deposition and expression of osteogenic markers.
This data further supports the hypothesis that hydroxyapatite induces osteogenesis, resulting in
decreased metabolic activity and proliferation. (Bernhardt et al., 2009; He et al., 2010)
Calcium deposition correlated with the expression of ALP and OCN in hASC cultured on
PETA:HA (85:15) and PETA:HA (80:20) scaffolds, which were significantly greater than
PCL:HA (80:20), pure PCL, and PETA control scaffolds in both media conditions, providing a
further indication that scaffolds composed of PETA may be an appropriate material for the repair
of bone defects. Increased alizarin stain uptake in PETA: HA (80:20) and PETA:HA (85:15),
compared to PCL:HA (80:20), does not correlate with increased cell density or metabolic activity
but does correlates with increased ALP and OCN expressionPETA is better able to induce the
expression of osteogenic markers than PCL, but further comparisons at differing concentrations
and with other degradable resins are required to test this hypothesis. . Cross sectional images of
PETA:HA (75:25) scaffolds demonstrate poor alizarin red penetration providing further support
that the void volume in not substantially interconnected.
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Although increasing HA content resulted in reduced pore size and interconnectivity, it
provided a more solid and stronger structure for the scaffold. Other studies have shown a similar
trend of decreasing porosity with increasing HA content.(Zhang & Ma, 1999) The increase in
compressive strength seen in solid samples is predictable and similar to that seen with other
nanoscale polymer fillers.(Ahn et al., 2004; Reynaud et al., 2001) As porosity played no role in
the solid samples, the increase in viscosity with increasing HA content beyond 15% did not
significantly affect the mechanical strength. Histological results demonstrated that both the presculpted and foamed in situ PETA:HA (80:20) scaffolds induced endochondral ossification.
Radiography results indicating increased densification further supported these findings. During
the in vivo study, the structure of the in situ polymerized foam sample may have been disrupted
when the surgical site was closed during the surgery. Poor porosity and interconnectivity could
be the reason why the densified regions of the radiographs were non-continuous. Overall results
suggest that PETA:HA scaffolds could be a suitable substrate for bone regeneration.
3.5. Conclusion
By gas foaming thiol-acrylate based copolymers synthesized via Michael addition with
an in situ amine-catalyst, a porous polymeric scaffold with bone-like morphology was developed
as a potential graft or augment in critical-sized bone defect repair. Not only does PETA:HA
composite have substantial porosity and interconnectivity, it also demonstrates adequate
mechanical strength as compared to cortical bone. Compared to PCL:HA composites, both
PETA:HA (85:15) and PETA:HA (80:20) scaffolds showed higher mineral deposition and ALP
and OCN expression level. Overall, the PETA:HA had higher compressive strength and
improved cytocompatibility compared to PCL controls. Mesenchymal cells cultured on PETA
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based scaffolds had a greater expression of osteogenic markers and the scaffolds exhibited
significantly greater mineralization than hASC cultured on PCL controls. The in vivo study
demonstrated that animals injected with PETA:HA composites showed no signs of surgical site
or systemic toxicity and that PETA:HA composites induced osteogenesis in vivo. Additionally,
the study serves as a proof-of-concept that gas foaming of thiol-acrylate polymers in vivo may be
used to conformally fill irregular sized defects.
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CHAPTER 4 TARGETING CALCIUM MAGNESIUM SLICATES FOR
POLYCAPROLACTONE/CERAMIC COMPOSITE SCAFFOLDS3
4.1 Introduction
In order to properly facilitate bone regrowth, synthetic composite scaffolds, grafts and
augments must be biocompatible, biodegradable, and provide adequate structural support for cell
migration, as well as waste and nutrient transport. These characteristics may be achieved by
manipulating tunable physical properties, such as porosity, modulus, degradation rate, absorption
rate, and swelling by modifications with the inclusion of copolymers and ceramic phases as
synthetic composite scaffolds.(Larrañaga et al., 2014; Wang et al., 2014) Synthetic bioceramics,
in particular calcium phosphates, have demonstrated high biocompatibility, osteoconductivity,
and osteoinductivity. These ceramics seek to mimic the natural hydroxyapatite (HA) crystal
formation found in bone.(Hench & Paschall, 1973; Hench et al., 1971; Pallua & Suschek, 2010)
Recently, silicon-based glass-ceramics, have been explored as an alternative to calcium
phosphates. Some members of this group have demonstrated desirable mechanical strength, high
bioactivity, and have been shown to enhance cell adhesion, proliferation, and mineralization of
extracellular matrix.(Gu et al., 2011; Kotobuki et al., 2005; Liu et al., 2008a)
Akermanite (Ca2MgSi2O7), a calcium, magnesium silicate, has been demonstrated to
have improved osteogenic properties compared to calcium phosphates (Ca3(PO4)2).(Haimi et al.,
2008; Sun et al., 2006) These properties may be attributed to the presence of Ca2+, Mg2+, and Si4+
ions, which increases recruitment and osteogenic commitment of hASCs.(Gu et al., 2011; Liu et
al., 2008a) In addition to superior osteogenic properties, akermanite (Ca2MgSi2O7) exhibits a
stable degradation rate, an important scaffold design consideration for bone regrowth.(Sun et al.,

3
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2006; Wu & Chang, 2007b)

Structurally similar to akermanite (Ca2MgSi2O7), diopside

(CaMgSi2O6) also supports osteoblast culture (Sun et al., 2006) and precipitation of surface
apatite.(Iwata et al., 2004a) The inclusion of diopside in Al2O3/diopside ceramic composites has
been shown to increase calcium deposition in simulated body fluid (SBF).(Zhang et al., 2010b)
This may be due to the structural similarities between akermanite and diopside. The structural
similarities of each ceramic presented herein can be seen in the crystal structures in order of most
three-dimensional to least three-dimensional in Figure 4.1. Although its potential as a biomaterial
has only recently been explored, merwinite has also been shown to induce apatite
formation(Hafezi-Ardakani et al., 2011) and osteoblast proliferation. (Ou et al., 2008)
Monticellite has been shown to possess similar properties, increasing apatite formation in
simulated body fluid (SBF) and stimulating osteoblast growth and adhesion in vitro. (Chen et al.,
2008)
While possessing favorable characteristics for osteoinduction, the clinical translation of
such bioactive glass-ceramics is severely limited by their brittle nature in pure form. However,
these mechanical limitations may be overcome by the fabrication of ceramic-polymer
composites. The inclusion of a polymer phase lends mechanical strength and tunable rheological
properties.(Zanetti et al., 2012a) Combined with the osteoconductive and osteoinductive
properties of bioactive ceramics, a more clinically relevant scaffold, graft or augment can be
fabricated.(Zanetti et al., 2013a) Natural compounds, including collagen and chitosan have been
employed in such composites.(Peter et al., 2010; Rodrigues et al., 2003) However, the ability to
control the chemical composition, as well as mechanical and biological properties make
biocompatible synthetic polymers a potentially more desirable alternative. Polycaprolactone
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(PCL), an FDA-approved material, displays high biocompatibility and a low degradation rate,
making it an ideal polymer phase for the slow growth process of bone regeneration.(Zanetti et
al., 2012a; Zanetti et al., 2013a)
Over 200,000 liposuction procedures are performed in the United States annually, and
from the resulting lipoaspirate, a great deal of hASCs can be derived. Multipotent hASCs have
been demonstrated to have similar morphology and differentiation capacity to those
mesenchymal stem cells isolated from bone marrow.(Levi & Longaker, 2011a) The hASCs are
capable of differentiating along the adipocyte, chondrocyte, neuronal, osteoblast, and skeletal
myocyte pathways. Abundant bone tissue engineering studies, as well as clinical trials, have
been conducted and shown impressive results by using hASCs.(Aksu et al., 2008; Cui et al.,
2007; Gabbay et al., 2006; Gimble et al., 2007; Yoon et al., 2007)
Herein, we present the preparation and comparison of composite polymer-ceramic
biodegradable materials composed of diopside (CaMgSi2O6), akermanite (Ca2MgSi2O7),
monticellite (CaMgSiO4), and merwinite (Ca3MgSi2O8).

Each ceramic was synthesized,

characterized via X-ray diffraction, and incorporated into composite PCL:ceramic scaffolds.
Mechanical testing was used to determine compressive yield strength and Young’s modulus for
each scaffold. Human adipose-derived stem cells (hASCs) viability and in vitro osteogenesis
were evaluated for each composite scaffold through extractive studies. To confirm osteogenic
properties, metabolic activity, calcium deposition, DNA content, and osteogenic markers alkaline
phosphatase (ALP) and osteocalcin (OCN), were quantified.

80

4.2. Materials and Methods
4.2.1. Synthesis of diopside (CaMgSi2O6), akermanite (Ca2MgSi2O7), monticellite
(CaMgSiO4), and merwinite (Ca3MgSi2O8)
Diopside (CaMgSi2O6), akermanite (Ca2MgSi2O7), monticellite (CaMgSiO4), and merwinite
(Ca3MgSi2O8) were synthesized by conventional ceramic methods with CaCO3 (99.95%),
MgCO3 (98.95%), and SiO2 (99.999%). All reagents were stoichiometrically weighed, mixed,
and grounded in an agate mortar and pestle (~ 20 min.), and powders were pressed into ~1 cm
pellets and annealed in alumina boats. After an initial calcination at 950 °C at a rate of 100 °C/h
for 48 h, multiple heat treatments were carried out up to 1300 °C at a rate of 100 °C with
intermediate grinding and re-pelletizing until reaching phase equilibrium. Monticellite
(CaMgSiO4) was obtained with heat treatments up to 1100 °C. Figure 4.1 shows the crystal
structures of the four ceramic materials considered in this work.
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Figure 4.1 Crystal structures of CaMgSi2O6, Ca2MgSi2O7, CaMgSi2O4, and Ca3MgSi2O8. Purple
spheres are Ca, red spheres are O, grey and blue polyhedra are Si and Mg, respectively.

4.2.2 Characterization of ceramics by powder X-ray diffraction
Diopside (CaMgSi2O6), akermanite (Ca2MgSi2O7), monticellite (CaMgSiO4), and
merwinite (Ca3MgSi2O8) were characterized by powder X-ray diffraction using a Bruker D8
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Advance X-ray diffractometer operating at 40 kV and 30 mA with a Cu Kα radiation source with
a LYNXEYE XE detector.

X-ray diffraction data were collected using Bragg Brentano

geometry from 2θ of 10° to 80° using a step size of 0.02 at a rate of 1s per step. Phase purity was
determined from calculated powder diffraction patterns.(Clark et al., 1969; Kuz'micheva et al.,
1995; Moore & Araki, 1972; Subbotin et al., 2008) The model of X-ray data (Table 4.1) of
diopside (CaMgSi2O6), akermanite (Ca2MgSi2O7), monticellite (CaMgSiO4), and merwinite
(Ca3MgSi2O8) were refined using TOPAS 4.2.8
Table 4.1 Unit cell parameters of akermanite (CaMgSi2O6), diopside (Ca2MgSi2O7), monticellite
(CaMgSiO4), and merwinite (Ca3MgSi2O8)
Unit Cell Parameters
Compound

CaMgSi2O6 Ca2MgSi2O7 CaMgSiO4

System

monoclinic

Space Group C2/c

Ca3MgSi2O8

tetragonal

orthorhombic monoclinic

𝑃4̅21 𝑚

Pbnm

P21 /c

a (Å)

9.74825(48) 7.9087(42)

4.7977(17)

13.1745(66)

b (Å)

8.92577(43)

11.0409(43)

5.2694(20)

c (Å)

5.25162(24) 5.0458(27)

6.3556(22)

9.3006(41)

β (°)

105.8862(30)

V (Å3)

439.495(37) 316.17(38)

-

-

336.66(21)

92.004(40)
645.26(49)

4.2.3 Fabrication of ceramic scaffolds
Diopside (CaMgSi2O6), akermanite (Ca2MgSi2O7), monticellite (CaMgSiO4), and
merwinite (Ca3MgSi2O8) powders (~1 g) were used to prepare the pure ceramic scaffolds as
previously described. The polyurethane foam templates 5 mm (height) x 10 mm (diameter) filled
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with diopside, akermanite, monticellite and merwinite slurry mixtures were incubated overnight
at 60 °C.
This was followed by annealing at 500 °C for 5 hours (after ramping up at a rate of 50
°C/h from room temperature.) in a box furnace, yielding porous diopside, akermanite,
monticellite and merwinite scaffolds.
4.2.4 Fabrication and characterization of PCL and PCL:ceramic scaffolds
Fabrication of PCL and PCL:ceramic scaffolds
A 10% (wt/vol) PCL solution in 10 mL of 1,4- dioxane was prepared. Akermanite,
merwinite, monticelite, and diopside were added to PCL individually at different weight ratios in
a PDMS mold with 10 mm x 5 mm wells, frozen overnight at -80 ᵒC and lyophilized in a freezedrier for 24 hours before use.
Micro-CT analysis and pore size determination
Two-dimensional (2-D) microcomputed tomography (μ-CT) imaging on pure akermanite,
monticellite, and diopside scaffolds was performed (40 kV and 540 ms) to obtain 0.04 mm
slices every 0.9° throughout a 360° rotation (SkyScan 1074, Skyscan n.v., Belgium). Threedimensional (3-D) files were reconstructed from 2-D images. Volume renderings were generated
through AVIZO 7.0.1 (Visualization Services Group)(Chen et al., 2014). Pore size was measured
through AVIZO 7.0.1 as well. Merwinite scaffolds were too fragile to image.
4.2.5 Porosity calculation based on micro-ct
To analyze the three-dimensional data, two dimensional slices were read into a custom
MATLAB code. For each slice the grayscale image was thresholded using Otsu’s method (Otsu,
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1975) and then converted into a binary image. Morphological operations were performed to
remove small imaging artifacts, and isolate interior and exterior pores(Chen et al., 2014). After
quantifying solid and void pixels, porosity was calculated as follows: ∅ = 𝑉

𝑉𝑝𝑜𝑟𝑒𝑠

𝑝𝑜𝑟𝑒𝑠 +𝑉𝑠𝑜𝑙𝑖𝑑

× 100%

4.2.6 Compression test
Composite and PCL composite scaffolds, molded into a 5 mm (height)×10 mm (diameter)
cylinder shape, were subjected to compression strain and the ultimate compressive strain tests.
Results were reported at 80 percent elongation at a compression rate of 1mm/min. Five samples
were tested for each group. The compressive strain of pure ceramic scaffolds was reported when
the samples reached the failure point using an Instron Mechanical Test System 5696, at an
extension rate of 0.5 mm/min.(Garber et al., 2013b)
4.2.7 Inductively coupled plasma atomic emission spectroscopy (ICP-OES)
0.1 gram of each ceramic were gas sterilized and then extracted in 5 mL of stromal media
for 7 days (n=3) at 37 oC. The supernatants were then collected and filtered through 0.22 µm
sterile filters after centrifugation of media from undissolved ceramic. Prior to elemental analysis
(ICP-OES), solutions were acidified with 1 mL of nitric acid, transferred to weighed ICP-OES
tubes, agitated for 2.5 h and diluted to a final volume of 10 mL with DI water. The final vials
were massed and run on a Varian Vista MPX.(Smoak et al., 2014)
4.2.8 hASCs isolation and culture
Liposuction aspirates from subcutaneous adipose tissue were obtained from at least three
donors. All tissues were obtained with informed consent under a clinical protocol reviewed and
approved by the Institutional Review Board at the Pennington Biomedical Research Center.
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Isolation of hASCs was performed according to previous work.(Gimble et al., 2010) The initial
passage of the primary cell culture was referred to as “Passage 0” (p0). The cells were passaged
after trypsinization and plated at a density of 5,000 cells/cm2 (‘‘Passage 1’’) for expansion on
T125 flasks in order to attain 80% confluency.(Garber et al., 2013b)
4.2.9 Extract cytotoxicity
Ceramic extractives from the degradation test were filtered (0.22 μm pore size) and
pipetted (100 μL/well) into a 96-well plate previously sub-cultured with hASCs (2,500 cells/well)
and incubated in a CO2 incubator at 37 °C containing 5% CO2 for 24 hours. The cellular viability
on scaffold cultures was determined using the alamarBlue® assay. 10 μL alamarBlue® reagent
was added to each well which were then re-incubated at 37 °C in 5% CO2 for 2 hours. The
fluorescence was measured using a fluorescence plate reader at an excitation wavelength of 530
nm and an emission wavelength of 595 nm. The tissue culture treated plastic 96-well plate served
as a control substrate.(Garber et al., 2013b)
4.2.10 hASCs loading on scaffolds and culture
5 μL (1.0  104 cells/μL) of Passage 2 from each donor (n = 3) were pooled and directly
loaded on the top of each sample. After 30 min of incubation at 37 °C and 5% CO 2, the opposite
side of each sample was loaded with the same number of cells by the same approach.
Experimental groups included: Ceramics (akermanite, merwinite, monticellite, or diopside):PCL,
75:25; 50:50; 25:75; and pure PCL, 0:100. Scaffolds loaded with hASCs were immediately
transferred to new 48-well plates and cultured in stromal media (DMEM, 10% FBS, and 1%
triple antibiotic solution) for 3 days followed by sample collection to assess cell viability with
alamarBlue® stain.
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4.2.11 In vitro hASCs viability on scaffolds with alamarBlue® stain
The viability of cells within the scaffolds in stromal media was determined after 3 days
using an alamarBlue® metabolic activity assay. The scaffolds were removed from culture,
washed three times in PBS, and incubated with 10% alamarBlue® in Hank’s balanced salt
solution (HBSS) without phenol red (pH 7) for 90 min. Aliquots (100 μL) of alamarBlue®/HBSS
were placed in a 96-well plate in triplicate, and the fluorescence was measured at an excitation
wavelength of 530 nm and an emission wavelength of 595 nm using a fluorescence plate
reader.(Zanetti et al., 2012a)
4.2.12. Osteogenic extract study
Each of the ceramics were suspended in DMEM F12 (0.5 g in 50 Ml) and placed on a
shaker at medium speed for 7 days at 37 oC. After this time period, each solution containing
ionic products from the ceramics dissolution was filtered with sterile 0.22 µm filters and
normalized to a 7.0 Ph. The media were then supplemented with 10% FBS and 1% triple
antibiotics. HASCs were cultured in stromal medium, osteogenic medium, and the adjusted
ceramic extractives for 21 days. The alamarBlue® conversion was measured at 7, 14, and 21 days.
Culture medium was removed from each scaffold, which was then washed three times in
phosphate buffered saline (PBS) and incubated with 10% alamarBlue® in Hank’s balanced salt
solution (HBSS) without phenol red (Ph 7) for 120 minutes. The ﬂuorescence of three aliquots
(100 L) from each scaffold was measured at an excitation wavelength of 530 nm and an
emission wavelength of 595 nm using a ﬂuorescence plate reader (Wallac 1420 multilabel hts
counter).

HASCs calcium deposition (cells cultured with stromal, osteogenic medium and

ceramic extractives) was assessed after 7, 14, and 21 days of culture by alizarin red staining.
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Wells of sterile tissue culture plates containing the cultured hASCs were washed with 0.9% NaCl
and ﬁxed with 10% formaldehyde for 10 minutes at RT. Wells were then stained with 2%
alizarin red for 10 minutes and washed with DI water three times to remove excess stain,
avoiding damage to the cells. Wells were then destained with 10% cetylpyridinium chloride
monohydrate for 4 hours at room temperature with constant agitation. Total DNA content was
used to determine the cell count on each scaffold as previously described.(Liu et al., 2008a) 0.5
Ml proteinase K (Sigma-Aldrich) at a concentration of 0.5 mg/Ml were added to each well, and
plates were kept at 56 ºC overnight to lyse the hASCs and release DNA. Aliquots (50 µL) were
mixed with equal volumes of 0.1 g/Ml Picogreen dye solution in 96-well plates. Samples were
then excited at 480 nm with a plate reader. Samples prepared without cells were used as blank
controls. Total RNA was extracted from cell-scaffold constructs as previously described.(Zanetti
et al., 2012a) Total RNA to Cdna EcoDry Premix (ClonTech) was used for Cdna synthesis. QrtPCR was performed using 2× iTaqTM SYBR® green supermix with ROX (Biorad) and primers
for alkaline phosphatase (ALP) and osteoscalcin (OCN)(Zanetti et al., 2012a) to quantify
osteogenic target gene expression of hASCs loaded onto the scaffolds and cultured in either
stromal or osteogenic media for 7, 14, and 21 days. Reactions were performed with a MJ MiniTM
Thermal Cycler (BioRad). The sequences of PCR primers (forward and backward, 50-30) were
as

follows:

ALP,

5’-AATATGCCCTGGAGCTTCAGAA-3’

CCATCCCATCTCCCAGGAA-3’;OCN,

5’-GCCCAGCGGTGCAGAGT-3’

and
and

5’5’-

TAGCGCCTGGGTCTCTTCAC-3’.Samples were normalized (ΔCt) against the house keeping
gene 18S Rrna and the – ΔΔCt value of ALP and OCN in scaffolds cultured in osteogenic and
control media was calculated using the ΔΔCt method.(Livak & Schmittgen, 2001a)
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4.2.13. Statistical analysis
All results were expressed as mean ± SEM. Data was analyzed with one-way analysis of
variance (ANOVA), followed by Tukey’s minimum significant difference (MSD) post hoc test
for pairwise comparisons of main effects. For all comparisons, a P-value < 0.05 was considered
significant. All significant differences among groups have been mentioned in the results and
discussion section.
4.3. Results and Discussion
4.3.1 Powder X-ray diffraction
A minor impurity is observed and the results indicate the phase targeted. The diffraction
results of the targeted CaMgSiO4 resulted in a two phase refinement of monticellite (95.9%) and
merwinite (4.10%). Multiple subsequent heat treatments up to 1100 °C led to the increasing
stability of merwinite. Figure 4.2 shows the X-ray powder diffraction patterns of diopside
(CaMgSi2O6),

akermanite

(Ca2MgSi2O7),

monticellite

(CaMgSiO4),

and

merwinite

(Ca3MgSi2O8).
SiO2

CaMgSi2O6

SiO2

Ca2MgSi2O7

*
Ca3MgSi2O8
SiO2

CaMgSiO4
*
Ca3MgSi2O8

*

Figure 4.2 Powder X-ray diffraction patterns of CaMgSi2O6 (black), Ca2MgSi2O7 (green),
CaMgSi2O4 (blue), and Ca3MgSi2O8 (red). * represents unidentified reflections
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4.3.2 Micro-Ct and porosity analysis of 100% ceramic scaffolds (Figure 4.3)
Micro-CT images and porosity analysis revealed that monticellite was the most porous
ceramic scaffold (34.17±13.07), followed by diopside (33.99±11.89), and akermanite
(32.41±11.32). There does not appear to be any significant difference in the porosity of these
scaffolds. The average pore size of diopside, akermanite and monticellite scaffolds is
0.844±0.157 mm, 0.838±0.172 mm, and 0.844±0.178 mm respectively. These results suggest
that the differences in mechanical strength between the ceramic scaffolds are due to differences
in three-dimensionality and crystal structure, not to the porosity of the material.

Figure 4.3 Micro-CT analysis of 100% ceramic scaffolds made diopside, akermanite and
monticellite
4.3.3 Compression analysis of 100% ceramic scaffolds
The 100 % ceramic scaffolds showed significant differences in compressive strength
from one another, as shown in Figure 4.4. Among the pure ceramic scaffolds, diopside
(CaMgSi2O6) scaffolds had the greatest compression strength (0.27 MPa), twice as strong as to
akermanite (Ca2MgSi2O7) with 0.12 MPa and six times stronger than monticellite
(CaMgSi2O4)(0.04 MPa) scaffolds.
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The compressive strength was significantly different between all groups. Merwinite
(Ca3MgSi2O8), in sharp contrast to diopside, was powdery after the annealing of poly-urethane
and poly vinyl alcohol, yielding 0 MPa compression strength.

Figure 4.4 Compressive strength and Young’s modulus of 100% ceramic scaffolds made with
diopside, akermanite, monticellite and merwinite respectively.
Diopside is monoclinic, akermanite is tetragonal, and monticellite and merwinite are
octahedral and monoclinic, respectively(Wu & Chang, 2007b) These differences in structural
dimensionality of the four silicates most likely contribute to differences in degradation and
mechanical strength. Merwinite’s insubstantial three-dimensional structure may explain its low
mechanical strength, ruling it out as a viable candidate for bone scaffold composites.
4.3.4. ICP-OES (Figure 4.5)
The Ca, Mg and Si concentrations in CaMgSi2O6, Ca2MgSi2O7, and CaMgSiO4
extractives were significantly higher in the ceramic experimental groups than in the stromal
medium control.

90

Crystal structure may affect the degradation rates of the ceramics, leading to differences
in their subsequent release profiles.(Ducheyne et al., 1993; Radin & Ducheyne,
1994) Additionally, diopside, akermanite, and monticellite absorb over 50% of phosphorus from
stromal medium. Merwinite precipitates almost all of the phosphorus as well as the magnesium
from stromal medium.

Figure 4.5 ICP-OES analysis of ceramic extractives from diopside, akermanite, monticellite and
merwinite.
4.3.5 Compression test of ceramic/PCL scaffolds
Compressive strength of all types of ceramic/PCL scaffolds are reported in Figure 4.6. In
general, PCL/ceramic composite scaffolds reach highest compressive strength at a 75:25 ratio of
PCL to ceramics. Further increasing the amount of ceramics to 50% in the PCL/ceramic
composite scaffolds causes the compressive strength to decrease. When the ceramic ratio reaches
75% in the composite scaffolds, the compressive strength of scaffolds drops below 0.02MPa
regardless of the ceramic type.
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Figure 4.6 Compressive strength and Young’s modulus of PCL: ceramic composite
scaffolds
It should be noted that merwinite/PCL, 75:25 scaffolds maintain little integrity during
normal handling and were consequently difficult to measure under compression test conditions
due to its low mechanical strength. Because all of the composite scaffolds were made via a
thermal-precipitation method, the ceramic phases tended to precipitate to the lower part of the
PCL/ceramic mixture in 1,4-dioxane. Phase separation may explain why the mechanical strength
of PCL/ceramic scaffolds decrease dramatically when ceramics comprise over 25% of the
composite.
When compared, the compressive strength of PCL/ceramic (75:25) composite scaffolds
followed a trend similar to that of the pure ceramic scaffolds. PCL/diopside (75:25) composite
scaffolds exhibit the greatest mechanical strength, followed by PCL/akermanite (75:25),
PCL/monticellite (75:25), and PCL/merwinite (75:25) composite scaffolds. PCL/ceramic (50:50)
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scaffolds all exhibited similar mechanical properties, indicating that varying concentrations of
PCL affects the performance of ceramics in the scaffolds.
4.3.6 Viability of hASCs after acute exposure (24 hours) to the seven-day media extractives
of different ceramic powders
alamarBlue® assay was used to determine the effect of ceramic component ions on
hASCs metabolic activity when cultured in the ceramic extracts (Figure 4.7). Cells exposed to
diopside extract and akermanite extract showed 80 % metabolic activity compared to the control,
which was cultured in stromal medium containing no ceramic extracts. There were no statistical
differences shown between the metabolic activity of hASCs cultured in diopside extracts,
akermanite extracts and monticellite extracts. However, hASCs cultured in merwinite extracts
were shown to exhibit significantly lower metabolic activity than those cultured in diopside
extracts, akermanite extracts, and the control. Even so, the cells cultured in merwinite extracts
showed above 70% relative metabolic activity.
4.3.7. Viability of hASCs on scaffolds for 3 days in stromal media
After characterization of the effects of ceramic extracts on hASCs cultured on sterile
tissue culture plates, the viability of cells cultured on PCL scaffolds containing varying
concentrations

of

ceramic additives was

measured

(Figure 8).

Results

from

the

alamarBlue®metabolic assay showed that the diopside and akermanite composites showed no
significant difference from the control containing no ceramic additives. Composite scaffolds
containing diopside and akermanite were shown to support the highest levels of relative hASCs
metabolic activity.
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Figure 4.7 Viability of hASCs after acute exposure (24 hours) to the 7 days media extractives of
different ceramic powder. *, significantly different, P<0.05
The merwinite additives at 25% and 50% as well as the monticellite additives at 25% and 75%
displayed no statistical differences in metabolic activity from the scaffold control containing no
ceramics. The merwinite additives at 75% formed a scaffold with very poor mechanical strength
and unstable structure. It failed to support hASCs growth, likely due to its rapid degradation in
stromal medium.
4.3.8. Osteogenesis study of hASCs cultured with ceramic extractives
Alizarin red staining was performed to evaluate the mineral deposition of hASCs cultured with
ceramic extractives (Figure-4.9A). All groups showed peak mineralization at 21 days of culture.

94

Figure 4.8 Viability of hASCs on Scaffolds for 3 days in Stromal Media
Among the ceramic groups, hASCs cultured with akermanite extractives showed the highest
level of calcium deposition, followed by monticellite and diopside. Merwinite exhibited the
lowest level of calcium deposition, lower than stromal medium negative control. Each of the
ceramic extractives displayed significantly lower osteogenic induction based on calcium
deposition in comparison to the positive control, osteogenic medium. qRT-PCR was performed
to assess the expression of commonly used osteogenic stage markers and total DNA content was
quantified using Quant-iT™ PicoGreen®, to analyze the hASCs proliferation in each
group.(Burge et al., 2007) The activation of genes such as ALP and OCN, indicative of osteoblast
activity, is the result of the osteogenic regulation and action on the transcription factor core
binding factor alpha1 (Cbfa1) by bone morphogenic proteins (BMPs).(Liu et al., 2008a; Milat &
Ng, 2009) ALP expression was measured 7 days after culture and OCN expression was measured
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after 14 and 21 days (Figure 4.8B). Both ALP and OCN up-regulation was observed in cultures
containing diopside, akermanite and monticellite extractives. Conversely, hASCs culture
containing merwinite extractives exhibited down regulation of ALP and OCN in comparison to
the stromal medium group. Among the ceramic groups, akermanite demonstrated the highest
ALP and OCN expression levels, followed by monticellite and diopside. This trend was in
accordance with calcium deposition levels.

The metabolic activity (Figure 4.9C) and

proliferation (Figure 4.9D) of hASCs cultured in stromal medium, osteogenic medium, and
ceramic extractives was also studied. Osteogenic medium displayed the lowest metabolic activity
at both 7 and 14 day time points. Calcium deposition and qRT-PCR data suggests that the hASCs
were committed to an osteogenic lineage at these time points, which has been demonstrated to
decrease metabolic activity.(Qureshi et al., 2013; Zanetti et al., 2012a) For the same reason,
akermanite and monticellite groups also exhibited decreased metabolic activity compared to
diopside and merwinte groups. Merwinite still shows a significant decrease in metabolic activity
21 days after culture and a decrease in total cell number, as indicated by total DNA analysis
(Figure 4.9D). Merwinite appeared to have a significantly decreased total cell number at 21 days
due to cell death. Merwinite still shows a significant decrease in metabolic activity 21 days after
culture and a decrease in total cell number, as indicated by total DNA analysis (Figure 4.9D).
Merwinite appeared to have a significantly decreased total cell number at 21 days due to cell
death. The most distinct difference in DNA content was seen between stromal medium and
osteogenic medium.
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Figure 4.9 Osteogensis study. A: calcium depostion of hASC cultured with diopside, akermanite,
monticellite and merwinite extractives repectively; B: q-rtPCR analysis of ALP (7 day) and OCN
(14 and 21 day) expression from hASC cultured with diopside, akermanite, monticellite and
merwinite extractives repectively; C: metabolic activity hASC cultured with diopside,
akermanite, monticellite and merwinite extractives repectively; D:total DNA amount of hASC
cultured with diopside, akermanite, monticellite and merwinite extractives repectively.
When correlated with calcium deposition, gene expression, and metabolic activity, the
steady number of cells between 7 and 21 indicates that hASCs have a lower proliferation rate
when committed to an osteogenic lineage. Akermanite and monticellite showed similar to trends
to osteogenic medium, further indicating similar osteogenic pathways are activated by the media
and ceramic induction.
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The hASC cultured in ceramic extractives has lower levels of osteogenic marker
expression compared to the positive control group, osteogenic medium. One hypothesis is that
this phenomena is related to the amounts of phosphorus absorption in the ceramics. Phosphorus
is important for cellular structure and function.(DiBartola & Willard, 2006) Phosphorous influx
into osteoblasts by means of a sodium-dependent phosphate co-transporter mechanism has
recently shown to trigger osteopontin mRNA and protein synthesis and to subsequently regulate
mineralization.(Beck et al., 2000) In addition, different ceramics release varying amounts of
calcium, magnesium and silicon, which are the crucial elements that stimulate gene transcription
during osteogenesis.(Gu et al., 2011) It is well known that calcium plays a crucial role in the
process of bone mineralization. However, the ability for extracellular calcium to regulate cellspecific responses has not been proven until recently.(Yamaguchi et al., 1998) Increased
extracellular calcium binding to G-protein-coupled extracellular calcium-sensing receptors has
been previously shown to induce osteoblast proliferation and chemotaxis. (Xynos et al., 2001)
Silicon plays a role in cross-linking glycosaminoglycan molecules with collagen and the
mineralization of human primary osteoblasts.(Seaborn & Nielsen, 2002) Likewise, Mg has a
close relationship with the bone tissue mineralization,(Di Mario et al., 2004; Kim et al., 2003b;
LeGeros, 1990) and Mg-substituted tricalcium phosphate, has been demonstrated to stimulate
adhesion and proliferation of human osteoblast cells compared to calcium phosphate
controls.(Sader et al., 2009) While merwinite was shown to release the greatest amount of
calcium, it also absorbed a high level of phosphorus from stromal medium, which led to cell
death and impeded the osteogenic differentiation. It is likely that as a result of severe
hypophosphatemia in merwinite extractives, exposed hASCs have osteogenic failure and cell
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death in 21 days. Furthermore, the increased level of silicon released by merwinite may be
responsible for the inhibition of cell proliferation observed.(Wu & Chang, 2007b) High silicone
concentration could induce cellular vacuole formation,(Valerio et al., 2004) which is often
associated with apoptosis or cell degeneration.(Serre et al., 1998) Diopside, on the other hand,
released only 44.8% of the magnesium and 61.3% of the calcium when normalized to release
from akermanite. Lower levels of these crucial ions may have led to the decreased osteogenic
properties observed.
4.4. Conclusion
The dimensionality of the crystal structure of ceramics plays an important role in the
fabrication of ceramic/polymer composite scaffolds. Increased three-dimensionality allows for
better stability and higher mechanical strength of the ceramic scaffolds, as well as limiting
scaffold phosphorous absorption from the environment. Furthermore,composite scaffolds
provide greater stability to support hASCs attachment and growth than pure ceramics. The
composites containing ceramics were also shown to degrade more slowly and maintain a
relatively intact structure after prolonged exposure to cell medium compared to polymer
scaffolds without ceramic additives as well as pure ceramic scaffolds. Overall, akermanite and
monticellite-containing composites exhibit better osteogenic properties than those containing
diopside and merwinite, suggesting that they might be the better ceramics for fabricating tissue
engineered bone scaffolds.
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CHAPTER 5. SUMMARY AND FUTURE WORK
The step growth nature of the amine catalyzed Michael addition reaction alleviated the
concern of unreacted monomer or radicals leaching into the body as would typically occur using
a chain-growth mechanism involving a free-radical process. In situ polymerization opens the
opportunity for the development of absorbable foams for the conformal repair of critical sized
tissue defects, which can be easily delivered in the clinical surgical setting. This represents a
substantial improvement over PCL, which are foamed externally prior to surgical insertion, and
methylmethacrylate bone cements, which are largely inert, non-porous, and permanent. The
SEM analysis, mechanical testing, and micro CT data prove that there is no distinct difference
between the PETA-co-TMPTMP foam made in situ and in vitro. While this material has many
advantages, future work includes the development of a homogenous HA containing polymer
network, osteogenic studies and improved mechanical strength of the foamed PETA-coTMPTMP with varying HA amounts. It is clear that scaffold technology plays a critical role in
the success of the current stem cell based bone tissue engineering paradigms. While a variety of
different materials, both ceramics and polymers have been tested in combination with hASC,
Lendeckel et al. and others note that composite scaffolds may offer a better clinical outcome as a
result of improved mechanical and biological properties.(Lendeckel et al., 2004) Calcium
phosphate nanoscale ceramic particles of HA and β-TCP will be used as the inorganic osteogenic
phase and thixotropic agent in future studies.
By gas foaming thiol-acrylate based copolymers synthesized via Michael addition with an in
situ amine-catalyst, a porous polymeric scaffold with bone-like morphology was developed as a
potential graft or augment in critical-sized bone defect repair. Not only does PETA:HA
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composite have substantial porosity and interconnectivity, it also demonstrates adequate
mechanical strength as compared to cortical bone. Compared to PCL:HA composites, both
PETA:HA (85:15) and PETA:HA (80:20) scaffolds showed higher mineral deposition and ALP
and OCN expression level. Overall, the PETA:HA had higher compressive strength and
improved cytocompatibility compared to PCL controls. Mesenchymal cells cultured on PETA
based scaffolds had a greater expression of osteogenic markers and the scaffolds exhibited
significantly greater mineralization than hASC cultured on PCL controls. The in vivo study
demonstrated that animals injected with PETA:HA composites showed no signs of surgical site
or systemic toxicity and that PETA:HA composites induced osteogenesis in vivo. Additionally,
the study serves as a proof-of-concept that gas foaming of thiol-acrylate polymers in vivo may be
used to conformally fill irregular sized defects.
The dimensionality of the crystal structure of ceramics plays an important role in the
fabrication of ceramic/polymer composite scaffolds. Increased three-dimensionality allows for
better stability and higher mechanical strength of the ceramic scaffolds, as well as limiting
scaffold phosphorous absorption from the environment. Furthermore, composite scaffolds
provide greater stability to support hASCs attachment and growth than pure ceramics. The
composites containing ceramics were also shown to degrade more slowly and maintain a
relatively intact structure after prolonged exposure to cell medium compared to polymer
scaffolds without ceramic additives as well as pure ceramic scaffolds. Overall, akermanite and
monticellite-containing composites exhibit better osteogenic properties than those containing
diopside and merwinite, suggesting that they might be the better ceramics for fabricating tissue
engineered bone scaffolds.
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